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ABSTRACT

Friedreich’s Ataxia (FA) is an autosomal-recessive, neurodegenerative disease
characterized by progressive lower extremity muscle weakness and sensory loss,
balance deficits, limb and gait ataxia, and dysarthria. FA is considered a sensory ataxia
because the dorsal root ganglia and spinal cord dorsal columns are involved early in the
disease, whereas the cerebellum is affected later. Balance deficits and gait ataxia are
often evaluated clinically and in research using clinical rating scales. Recently,
quantitative tools such as the Biodex Balance System SD and the GAITRite Walkway
System have become available to objectively assess balance and gait, respectively.
However, there are limited studies using instrumented measures to quantitatively
assess and characterize balance and gait disturbances in FA, and longitudinal,
quantitative analyses of both balance and gait have not been investigated in this patient
cohort. The purpose of the present study was to characterize gait patterns of adults with
FA and to identify changes in gait and balance over time using clinical rating scales and
quantitative measures. Additionally, this study investigated the relationship between
disease duration, clinical rating scale scores and objective measures of gait and
balance.
This study used a longitudinal research design to investigate changes in balance
and gait in 8 adults with genetically confirmed FA and 8 healthy controls matched for
gender, age, height, and weight. Subjects with FA were evaluated using the Berg
vi

Balance Scale (BBS), the Friedreich’s Ataxia Rating Scale (FARS) and instrumented
gait and balance measures at baseline, 6 months, 12 months and 24 months. Controls
underwent the same tests at baseline and 12 months. Gait parameters were measured
utilizing the GAITRite Walkway system with a focus on gait velocity, cadence, step and
stride lengths, step and stride length variability and percent of the gait cycle in swing,
stance and double limb support. Balance was assessed using the BBS and the Biodex
Balance System; the latter included tests of postural stability and limits of stability.
At baseline, there were significant differences in gait and balance parameters,
BBS scores and FARS total scores between FA subjects and controls as determined
using paired t-tests (p<0.05). Adults with FA walked slower, showed decreased
cadence, took shorter strides, exhibited greater gait variability and spent less time in
swing phase and more time in stance phase and double limb support. In addition,
subjects with FA exhibited higher postural stability indices and lower limits of stability
overall directional control scores (p<0.05). In the control group, with the exception of the
limits of stability forward directional control score (p=0.008), no other significant
changes in clinical rating scale scores or gait and balance measures were apparent.
Using linear mixed effect (LME) modeling, several gait parameters of subjects with FA
exhibited a significant linear change from baseline to 24 months including: gait velocity
and cadence during comfortable and fast walking, step and stride length during
comfortable and fast walking, and step length variability during fast walking (p<0.05).
The LME also revealed a significant linear change in BBS scores, in the postural
stability overall stability and anterior posterior indices, and in the limits of stability
backward directional control scores (p<0.05). Numerous significant correlations were
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noted between disease duration, BBS scores and FARS total scores and balance and
gait parameters. Of particular note was the strong association between clinical rating
scale scores, balance parameters and step and stride length variability (p<0.05).
This is the first longitudinal study to demonstrate changes over time in gait and
balance of adults with FA using both quantitative measures and clinical rating scales.
This study provided a detailed characterization of the gait pattern and balance of adults
with FA. The GAITRite Walkway system proved to be a sensitive measure, and able to
detect subtle changes in gait parameters over time in adults with FA. In addition, the
BBS was an appropriate and sensitive assessment to detect changes in static and
dynamic balance in this patient cohort. Finally, results revealed a strong and consistent
relationship between clinical rating scale scores, postural stability indices, limits of
stability scores, and step and stride length variability in individuals with FA.

viii

CHAPTER ONE
INTRODUCTION

What is Ataxia?
Ataxia is incoordination of movement due to causes other than primary muscle
weakness. Ataxia can be caused by damage to motor or sensory regions of the central
nervous system, as well as from peripheral nerve pathology, but the most common
cause of ataxia is damage to the cerebellum (Bastian, 1997).

Some of the most

distinctive clinical signs of ataxia are impairments of balance and gait. Balance
abnormalities are characterized by increased postural sway, decreased limits of stability
(LOS), excessive responses to perturbation, poor control of equilibrium during motions
of other body parts, and abnormal oscillations of the trunk (titubation). Gait ataxia, or
walking incoordination, has distinctive features including unsteadiness, reduced step
and stride length, irregular foot trajectories, variable foot placement, a veering path of
movement, abnormal interjoint coordination patterns and sometimes a widened stance
(Earhart et al., 2001; Morton et al., 2004; 2010; Palliyath et al., 1998).
There are three types of ataxia: cerebellar, sensory and vestibular. Cerebellar
ataxia can result from degenerative disease, stroke, or from tumors of the cerebellum.
Damage to the pathways that provide input to or output from the cerebellum can also
result in ataxia. These pathways include the dorsal and ventral spinocerebellar
pathways, the corticopontocerebellar pathway and the cerebellar peduncles (which
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relay information in and out of the cerebellum). Demyelinating diseases such as multiple
sclerosis can lead to ataxia due to loss of signal propagation in any of the structures
mentioned. Damage to nervous system structures such as the thalamus, which receive
cerebellar input, can cause ataxia and tremor. Ataxia can also be caused by disruption
of sensory and proprioceptive input from the periphery. This “sensory” ataxia results
from damage to sensory afferents in peripheral nerves, dorsal root ganglion cells, dorsal
nerve roots entering the spinal cord, and the dorsal columns of the spinal cord. Sensory
ataxia can be distinguished from cerebellar ataxia, because in the former signs and
symptoms worsen significantly when movements are made with the eyes closed
(Bastian, 1997; Lundy-Ekman, 2007). Individuals with sensory ataxia are able to
compensate for the loss of distal somatosensory input through the use of vision and will
often watch their feet as they walk. However, balance deficits become much more
pronounced when the person closes their eyes. Individuals with sensory ataxia also
show impaired proprioception and vibratory sense, which is intact in those with
cerebellar ataxia. Some diseases, such as Friedreich’s Ataxia (FA), can lead to a mixed
sensory and cerebellar ataxia. Ataxia can also result from vestibular disorders, though
this is not as common. Vestibular ataxia must be differentiated from cerebellar or
sensory ataxia through clinical examination of the three systems. In vestibular disorders,
abnormal vestibulospinal, corticospinal, reticulospinal, or tectospinal tract activity cause
disequilibrium, imbalance and ataxia (Lundy-Ekman, 2007).
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Anatomy of Ataxia
The Dorsal Column Medial Lemniscal System
Regulation of movement and balance by the cortex and cerebellum is highly
dependent upon sensory afferent information. Peripheral sensory receptors and
peripheral nerves provide information to the central nervous system about position of
the limbs, position of the body in space and about the environment in which the person
is moving. Information related to discriminative touch and conscious proprioception is
conveyed from the peripheral nervous system to the brain via the dorsal column medial
lemniscal system. Discriminative touch allows for localization of touch and vibration.
Conscious proprioception is awareness of movement and the ability to sense the
position of one’s body parts in space. Sensation, which requires precise localization on
the body surface, is mediated by the dorsal column medical lemniscal system. This
information is used to make movements smooth, and disruption of this system can
result in movement incoordination and balance deficits.
The dorsal column medial lemniscal system uses a three neuron relay system
(Lundy-Ekman, 2007) as depicted in Figure 1. The primary, first order neuron conveys
information from the distal sensory receptor to the medulla. The second order neuron
conveys information from the medulla to the thalamus and the tertiary neuron conveys
information from the thalamus to the somatosensory cortex. Components of the medial
lemniscal system include distal sensory receptors, peripheral nerves, cells in the dorsal
root ganglia, tracts in the dorsal column of the spinal cord, brainstem nuclei, parts of the
thalamus and the somatosensory cortex. Stimulation of sensory receptors at the distal
end of the primary neuron generates action potentials which travel to the cell body
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Figure 1. Dorsal Column Medial Lemniscal System
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located in the dorsal root ganglion. The primary neuron’s proximal axon enters the
spinal cord in the dorsal root and ascends in the ipsilateral dorsal column. Axons from
the lower limb occupy the more medial portion of the dorsal column, named the
fasciculus gracilis. Axons from the upper limbs occupy the lateral portion of the dorsal
column, named the fasciculus cuneatus. Fibers that ascend in these spinal cord tracts
synapse with second order neurons in the nuclei gracilis and cuneatus of the medulla.
Axons from these second order neurons then decussate and ascend as the medial
lemniscus terminating in the ventral posterolateral nucleus of the thalamus. Thalamic
third order neurons relay information to the somatosensory cortex after passing through
the internal capsule (Lundy-Ekman, 2007). The dorsal column medial lemniscal system
is composed of large, myelinated, rapidly conducting fibers. These large, myelinated
fibers have high energy demands and are particularly vulnerable to the oxidative stress,
cell damage and demyelination seen in neurodegenerative diseases such as FA (Morral
et al., 2010). The medial lemniscal system is one of the first nervous system areas
involved in FA and it is critically important to coordinated movement, balance and gait
because it is responsible for afferent transmission of discriminative sensations and
proprioception.

The Cerebellum and Spinocerebellar System
The human cerebellum has three primary regions (Purves et al., 2008). The
cerebrocerebellum includes the most lateral parts of the cerebellar hemispheres. It
receives input from the cerebral cortex via the pontine nuclei and sends fibers to the
ventrolateral thalamus which then connect to the primary and pre-motor cortical areas.
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The cerebrocerebellum is involved in planning movements and evaluating sensory
information during movement. The vestibulocerebellum (floculonodular lobe) receives
inputs from the semi-circular canals and the brainstem vestibular nuclei and sends
fibers back to the vestibular nuclei. The vestibulocerebellum primarily regulates
movements underlying postural control, balance and equilibrium, as well as the
vestibulo-ocular reflex. The spinocerebellum consists of the more medial and
intermediate parts of the cerebellar hemispheres. The medial strip is called the vermis
and is primarily responsible for trunk and proximal limb movements. The intermediate
section, called the paravermis, is concerned with distal limb movements. The
spinocerebellum receives proprioceptive input from the dorsal column medial lemniscal
system, the trigeminal nerves and from visual and auditory systems and sends fibers to
the deep cerebellar nuclei, which then project to the cerebral cortex to modulate
descending motor systems.
The spinocerebellum can elaborate spinal proprioceptive input to anticipate
future positions of body parts during movements – a feed forward motor control system.
It does this by receiving input from proprioceptors within muscles (muscle spindles and
golgi tendon organs) and through feedback input from the spinal cord pattern
generators. Input from the trunk and lower extremities to the spinocerebellum is greater
than that from the upper extremities. Input from the spinal cord travels to the
spinocerebellum via two pathways: the dorsal and ventral spinocerebellar tracts.
Information that travels in these tracts is not consciously perceived. The dorsal
spinocerebellar tract relays precise information about individual muscle activity and
provides sensory feedback during movement. The ventral spinocerebellar tract appears
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to be involved in rhythmic, automatic movements such as walking. The spinocerebellum
also receives information from the cortex about motor commands. It is, thus,
responsible for comparing ongoing movements (input from muscles and joints) with
intended movements (input from cortex) for both voluntary movement and rhythmic,
automatic movements like walking. When the function of the spinocerebellum or its
afferent and efferent pathways is impaired, balance and gait disturbances occur.
The central cerebellum contains four deep nuclei: the dentate nucleus, two
interposed nuclei (emboliform and globose) and the fastigial nucleus. Each nucleus
receives input from different parts of the cerebellar cortex and most output fibers from
the cerebellum originate from these deep nuclei. The dentate nucleus is the largest and
most lateral of the four pairs of deep nuclei. It receives afferent information from the
premotor and supplementary motor cortex and sends efferent signals via the superior
cerebellar peduncle to the ventrolateral thalamus. Dorsal dentate fibers project to motor
areas of the cerebral cortex and are thought to be responsible for the planning, initiation
and control of voluntary movements. The ventral region of the dentate nucleus projects
to prefrontal and posterior parietal cortical areas and is proposed to be involved in
conscious thought and visuospatial functions (Dum et al., 2003).

Friedreich’s Ataxia
Friedreich’s Ataxia (FA) is a progressive, neurodegenerative disease, which can
affect multiple body systems, with symptoms ranging from gait and balance
disturbances to cardiomyopathy and diabetes (Marmolino, 2011). FA is the most
prevalent inherited ataxia, affecting about 1 in every 50,000 people with a carrier
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prevalence of 1 in 110 people (Friedman, 2010; Maring et al., 2007). FA is an
autosomal recessive disorder caused by mutations in the frataxin gene (FXN) mapped
on chromosome 9q13 (Marmolino, 2011). Autosomal recessive means that an individual
can only develop disease if they inherit a copy of the defective gene from both parents.
The FXN gene encodes a small mitochondrial protein called frataxin, an 18 kDa
soluble protein with 210 amino acids. FA results from a deficiency of this frataxin
protein, typically expressed at 5-30% of normal levels (Campuzano et al., 1997). There
are 3 types of FXN mutations: the expanded GAA repeat; premature termination of
translation; or a loss-of-function missense mutation. Each of these mutations causes a
loss of frataxin function. The last two mutations cause either a decrease in frataxin
levels or in its incorrect function despite normal levels. The expanded GAA repeat
results in stopping transcription of the FXN gene by inducing heterochromatin formation
in the flanking sequence or by adopting an abnormal DNA structure (Bidichandani et al.,
1998). These mechanisms result in a severe deficiency of FXN transcription, thus a
deficiency in frataxin protein. The frataxin protein deficiency is in direct proportion to the
length of the expanded GAA repeat and is the reason that repeat length correlates with
disease severity and rate of progression. A direct correlation has been established
between the size of the GAA repeat and an earlier age of onset, more rapid rate of
disease progression, earlier age of confinement to a wheelchair, cardiomyopathy, and
the presence of other complications such as diabetes, scoliosis, visual or hearing loss
(Pandolfo, 2009).
The most common genetic mutation in FA is the GAA repeat expansion within
the first intron of the FXN gene. In healthy individuals, the number of repeats ranges
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from 6 to 36, but in people with FA the repeats can range from 70-1700, most
commonly 600-900 (Schmucker et al., 2010). Most patients with FA (96%) have two
expanded GAA alleles, which causes reduced frataxin expression in all body tissues. A
small number of FA patients (4%) are heterozygous with a GAA repeat mutation on one
allele and a micromutation on the other allele. The FXN gene is expressed in all cells of
the body but at variable levels, which can be accounted for only partially by differences
in mitochondria (Pandolfo, 2009). The tissues that are affected primarily in FA normally
express high levels of frataxin. Campuzano et al. (1997) showed that the highest level
of frataxin expression is in the heart with intermediate levels in the liver, skeletal
muscles and pancreas. Similar studies of the central nervous system showed high
levels of expression in the dorsal root ganglion, the spinal cord, less in the cerebellum,
and very little in the cerebral cortex (Delatycki et al., 2000). It has been demonstrated in
knock-out mice that total absence of frataxin protein leads to early embryonic death
(Puccio, 2009).
The physiological effects of frataxin deficiency include a disruption of iron-sulfur
cluster enzymes, excess iron in the mitochondria and cellular inability to regulate iron
levels, thus an increased sensitivity to oxidative stress. Early evidence linking frataxin to
iron metabolism was the discovery of increased iron levels in the hearts of patients who
had succumbed to FA. Studies utilizing mouse models with frataxin deletions in specific
tissues demonstrated that the primary problem at the cellular level in FA is the ironsulfur cluster protein deficiency followed by secondary mitochondrial iron accumulation.
It is accepted that frataxin deficiency leads to mitochondrial and extra-mitochondrial
iron-sulfur cluster deficits. This research suggests that frataxin has a critical role in
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regulation of mitochondrial iron transport (Schmucker et al., 2010). Thus, frataxin
deficiency leads to a loss of iron-sulfur clusters, which leads to mitochondrial
impairment. The mitochondrial impairment then leads to an increased production of
reactive oxygen species, which often results in excess free radicals. The excess free
radicals result in cell damage and cell death particularly in tissues with high energy
demands such as cardiac muscle, pancreatic islet cells and nervous system cells
(Maring et al., 2007).
The primary and early nervous system changes in FA include neuronal cell loss
and shrinkage in the dorsal root ganglia and the dorsal columns of the spinal cord (Della
Nave et al., 2008; Marmolino, 2011). There is degeneration of the gracilis and cuneatus
tracts in the dorsal column and of the spinocerebellar tracts in the lateral columns of the
spinal cord (Della Nave et al., 2008; Lamarche et al., 1984). Secondary neuronal loss in
the brainstem involves the cuneate and gracilis nuclei of the dorsal medulla. There is a
striking loss of neurons and loss of myelinated fibers in the dentate nucleus of the
cerebellum, whereas the cerebellar cortex is spared (Della Nave et al., 2008;
Marmolino, 2011). Cell loss and astrocytosis also occur in the brainstem vestibular and
cochlear nuclei and in the superior olives, whereas the inferior olives are spared. The
other deep nuclei (interposed and fastigial) and efferent pathways of the cerebellum and
the corticospinal tracts degenerate much later in the disease (Della Nave et al., 2008;
Lamarche et al., 1984). There is gray matter volume loss in the dorsal medulla, rostral
cerebellar vermis, and in the inferomedial cerebellar hemispheres in FA, but no atrophy
of the cerebral hemispheres (Della Nave et al., 2008).
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The neurological signs and symptoms of this inherited disease correlate closely
with the degenerative changes occurring in the nervous system. Symptoms usually
begin between the ages of 5 and 15 and typically present as gait and limb ataxia and
balance deficits (Delatycki et al., 2000). There is a gradual loss of position and vibratory
sense and light touch sensation in the extremities with the pattern of loss starting distal
and symmetrical and progressing proximally (Maring et al., 2007). Incoordination and
intention tremor develop in all extremities with progressive and symmetrical loss of
muscle strength (lower extremities > upper extremities and trunk). Lower extremity deep
tendon reflexes are diminished early, while spasticity and positive plantar reflexes
(positive Babinski sign) are seen later in the disease due to corticospinal tract
degeneration. A positive Babinski sign involves dorsiflexion of the great toe with fanning
of the other toes upon stimulation of the sole of the foot (Lundy-Ekman, 2007). Lower
extremity muscle weakness begins in the hip extensors and abductors, but as the
disease progresses, distal limb muscle weakness and muscle wasting become
pronounced. The upper extremity and trunk musculature are spared until later in the
disease process. Spasticity in the lower extremities affects the ankle plantarflexors and
invertors leading to ankle equinovarus deformity later in the disease (Maring et al.,
2007).
Individuals with FA develop progressive ataxia beginning with impaired balance
when walking and incoordination of the lower limbs more than the upper limbs. Gait
ataxia, caused by a combination of spinocerebellar degeneration and loss of
proprioceptive and vibratory sense in the lower extremities is often the earliest
symptom. Within five years of symptom onset, most people with FA exhibit dysarthria
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(slurred speech), lower extremity muscle weakness and diminished or absent joint
position and vibratory sensation particularly in the feet. Involvement of peripheral
sensory neurons and motor neurons result in a progressive, mixed axonal, peripheral
neuropathy. Other problems associated with FA include scoliosis, pes cavus, optic
nerve atrophy with visual loss, abnormal extraocular movements, sensorineural hearing
loss, bladder incontinence, and autonomic disturbances. Spinal scoliosis is present in
66% of people with FA and can become pronounced requiring bracing or surgery.
Diabetes occurs in 30% of individuals with FA and many more have impaired glucose
tolerance. Hypertrophic cardiomyopathy, defined as an increased thickness of the
interventricular septum, is present in 66% of people with FA (Delatycki et al., 1999).
Cardiac changes can also include increased left ventricular wall thickness and
increased left atrial diameter, all leading to inefficient cardiac function and impaired
aerobic capacity (Maring et al., 2007).
Typical FA presents prior to the age of 25 years, with the average age of onset in
the early to mid-teen years (Delatycki et al., 2012). There are two main types of atypical
FA: FA with retained reflexes and late onset FA (LOFA). Late onset FA is found in 14%
of individuals with this disease and is defined as symptom onset after 25 years of age
(Delatycki et al., 2012). Disease progression is usually slower in LOFA than in typical
FA with later age of confinement to a wheelchair and a lower incidence of
musculoskeletal abnormalities (Lynch et al., 2006). The rate of progression in typical FA
is variable with the average time from symptom onset to wheelchair dependence
approximately ten years and the average age of death at about 37 years of age. Death
is usually due to progressive cardiomyopathy or aspiration pneumonia (Maring et al.,
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2007). Involvement of the spinal cord dorsal columns, spinocerebellar and corticospinal
tracts and the cerebellar dentate nuclei contribute to the neurological sequelae of FA,
and it is likely that the sensory neuropathy contributes to the disability observed in these
individuals (Morral et al., 2010).

Clinical Rating Scales
Recently, there has been a focus on the development of effective clinical rating
scales for FA. Clinical trials require valid methods to assess how people with FA change
over time or how they respond to treatment interventions (Friedman, 2010). The
International Cooperative Ataxia Rating Scale (ICARS) and the Friedreich’s Ataxia
Rating Scale (FARS) are two clinical rating scales most commonly used to evaluate
disease severity and progression in people with FA (Delatycki, 2009). Although the
Scale for the Assessment and Rating of Ataxia (SARA) was originally developed to
assess people with Spinocerebellar Ataxia (SCA), it has begun to be used to assess
people with FA (Delatycki, 2009). Many of the rating scales utilized in FA have not been
developed using rigorous psychometric assessment methods (Delatycki, 2009). Most
scales are scored based on examination of a patient’s abilities by a trained evaluator,
which could limit reliability and sensitivity. The Berg Balance Scale is a valid and reliable
test of static and dynamic balance which has been tested for validity and reliability in the
elderly and other neurological populations but not in FA.
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International Cooperative Ataxia Rating Scale
The ICARS is a clinical rating scale developed by a committee of the World
Federation of Neurology for use in clinical trials of cerebellar ataxia (Trouillas et al.,
1997). It is a 100 point, semi-quantitative scale which includes 19 items divided into 4
unequally weighted sub-scales: posture and gait disturbance (7 items, 34 points); limb
ataxia (7 items, 52 points); dysarthria (2 items, 8 points); and oculomotor disorder (3
items, 6 points) (Saute et al., 2011; Storey et al., 2004). A higher score is indicative of
more severe ataxia. The ICARS has been found to have high inter-rater reliability in a
study in which 3 neurologists independently assessed videotaped examinations of
patients with FA or SCA (Storey et al., 2004). The psychometric properties of the ICARS
were also assessed in a study of 77 people with FA (Cano et al., 2005). Results showed
that the total ICARS score satisfied all psychometric properties including validity and
reliability. The posture and gait sub-scale also performed well, yet the other three subscales did not pass the tests of validity or reliability (Cano et al., 2005). These authors
concluded that although the ICARS total score satisfied basic psychometric tests, its
validity as a measure of overall ataxia severity or change over time in FA is uncertain. A
longitudinal study showed the ICARS to have a significant ceiling effect when used to
examine neurologic and cardiac changes over time in people with FA (Ribai et al.,
2007). These authors concluded that qualitative clinical rating scales such as the ICARS
were not appropriate to follow neurologic progression over long disease durations. They
suggested the use of more quantitative measures, which can be used in addition to the
ICARS.
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Friedreich’s Ataxia Rating Scale
The Cooperative Ataxia Group developed the FARS (Subramony et al., 2005) as
a measure of disease severity in FA. The FARS has a maximum score of 159 points
with higher score denoting more severe disease. The FARS includes three sub-scales:
functional staging for ataxia (6 points); activities of daily living (ADL) (36 points); and the
neurological exam (117 points). The neurologic exam sub-scale comprises bulbar (11
points), upper limb coordination (36 points), lower limb coordination (16 points),
peripheral nervous system (26 points), and upright stability and gait functions (28
points). Functional performance measures have been added to the FARS (referred to
as FARS IV) and include the nine hole peg test, timed 25 foot walk test, and the PATA
rate; the number of times the word “PATA” can be repeated and recorded in 10
seconds. The nine hole peg test is a test of upper limb coordination and speed and the
timed 25 foot walk test is a gait assessment using a timed walk of 50 feet (25 feet each
way), which can be completed with or without a gait assistive device.
Subramony and colleagues (2005) developed and first tested the psychometric
properties of the FARS in a small study of 14 subjects with FA. They found the FARS to
have excellent inter-rater reliability with an inter-class correlation coefficient (ICC) of
0.95 for the total neurological exam score. Excellent inter-rater reliability with high ICC
was also shown for disease stage, ADL, upper limb coordination, lower limb
coordination, upright stability and gait, total neurological exam score, PATA rate, nine
hole peg test, and timed 25 foot walk test. Bulbar (0.29) and peripheral nerve (0.74)
items showed less inter-rater reliability (Subramony et al., 2005). A larger study
assessed 155 people with FA and found that FARS scores, performance measure
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scores and performance measure composite scores (FARS IV) correlated with disease
duration, functional disability, ADL, and with quality of life measures (Lynch et al., 2006).
These authors concluded that their results support the validity of the FARS and
functional performance tests as clinical measures of FA disease progression. In a
longitudinal study of 43 people with FA, the FARS was compared with the ICARS, the
Functional Independence Measure (FIM) and the Modified Barthel Index (Fahey et al.,
2007). The FARS was highly correlated with the other three measures. The FARS,
ICARS and FIM, but not the Modified Barthel Index, were able to show FA disease
progression over 12 months. The results showed a mean worsening on the FARS of
9.5/159 points with an effect size of 0.34. Based on effect size and power analysis,
these authors concluded that the FARS may be the best scale to use in clinical trials of
FA (Fahey et al., 2007). Another study reported on disease progression in 168 people
with FA after 12 and 24 months (Friedman, 2010). These authors concluded that FARS
total scores and functional composite measures capture FA disease progression, but
with greater sensitivity to change after two years compared to one year (Friedman,
2010).

Scale for the Assessment and Rating of Ataxia
The SARA was developed to measure severity of ataxia and was validated for
use with people with autosomal dominant SCA (Schmitz-Hubsch et al., 2006). The
SARA has only eight items with the total score ranging from 0 (no ataxia) to 40 (most
severe ataxia). The eight items include gait (8 points), stance (6 points), sitting (4
points), speech disturbance (6 points), finger chase (4 points), nose to finger test (4
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points), fast alternating hand movements (4 points), and heel-shin slide (4 points). The
last 4 items (Items 5 through 8) are called limb kinetic functions in which the left and
right limbs are scored separately, averaged together, and then included in the total
score. The internal consistency of the SARA was studied in a large European multicenter trial (Schmitz-Hubsch et al., 2006). The SARA showed very high inter-rater
reliability, with an ICC of 0.98. Most individual test items also showed good inter-rater
reliability with ICCs > 0.80. Test-retest reliability was high with an ICC of 0.90 and
internal consistency was also high. The total SARA score increased with disease stage
(p<0.001) and was correlated with the Barthel Index (r=0.80) and the functional
assessment sub-scale of the Unified Huntington’s Disease Rating Scale (r=0.89),
however, the SARA showed weak correlation with disease duration (r=0.34) (SchmitzHubsch et al., 2006). These authors concluded that the SARA was a valid and reliable
measure of ataxia and was appropriate for use in clinical trials. Burk and colleagues
(2009) tested the validity and reliability of the SARA for use in FA. Ninety six subjects
with FA were rated using three different clinical rating scales: the FARS, ICARS and
SARA. The SARA showed an ICC of 0.99, internal consistency for each individual test
item of 0.89, and all items demonstrated high construct validity (Burk et al., 2009). The
SARA was highly correlated with the ICARS (r=0.953) and FARS (0.938) total scores.
The total SARA score also correlated with ADLs (r=0.929) and with disease duration
(r=0.712). The SARA may be used more in future studies of FA as it is considered valid
and reliable as well as quick and easy to administer (Delatycki, 2009).
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Berg Balance Scale
Balance impairments are common sequelae of FA and yet there are no
standardized assessments which have been validated to strictly assess balance in this
population. The clinical rating scales reviewed include balance items, however, none of
these scales focus on balance assessment. The Berg Balance Scale (BBS) is a 14 item
test that was developed originally to assess static balance and falls risk in the
community dwelling elderly (Berg, 1989; Berg et al., 1995; 1992). The test is easy and
takes only about 20 minutes to administer requiring minimal equipment. The items on
the BBS were developed to evaluate a person’s ability to maintain their position, adjust
their position during active movements, and respond to external inputs (Datta et al.,
2009). The BBS items are in order of increasing difficulty by either decreasing the base
of support, moving from sitting to standing, or standing on one leg to step up onto a
stair. The psychometric properties of the BBS have been tested in the community
dwelling elderly and those with stroke, spinal cord injury and multiple sclerosis and it
has been found to be a highly valid and reliable tool for use with these populations
(Berg et al., 1995; 1992; Blum et al., 2008; Cattaneo et al., 2007; 2006; Mao et al.,
2002; Wirz et al., 2009). The BBS is commonly used among physical therapists to
assess balance in neurological populations. The BBS has been used in intervention
studies with patients with spinocerebellar ataxia, sporadic olivopontocerebellar atrophy
and sensory ataxia (Ilg et al., 2009; Landers et al., 2009; Missaoui et al., 2013; Riva et
al., 2014). However, it has not been investigated for assessment of balance in people
with FA.
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More research is needed to identify valid and reliable measures of FA disease
progression that permit clinical trials of therapeutic agents and interventions to be
conducted within a reasonable period of time. With the expense of clinical trials and the
difficulty in recruiting people with FA, measurement tools that enable properly powered
trials with as few subjects as possible in as short a time frame as possible need to be
developed further and validated (Delatycki et al., 2012). Although the clinical rating
scales reviewed are widely used, they do not quantitatively identify balance deficits and
gait deviations characteristic of ataxia.

Postural Control in Ataxia
People with FA have postural control and gait impairment that contribute to their
loss of functional ambulation. Impaired postural control is considered a hallmark of
ataxia. Postural control involves controlling the body’s position in space for dual
purposes of stability and orientation (Shumway-Cook et al., 2007). A person must
maintain an appropriate orientation between their body and body segments in relation to
the environment to avoid loss of balance and falls. Balance is the ability to control one’s
center of mass (COM) in relationship to the base of support (BOS) in any given sensory
environment (Shumway-Cook et al., 2007). Center of pressure (COP) is the average of
total forces applied by the individual onto the support surface on which the person is
standing. Researchers use center of mass and center of pressure interactions to study
the efficacy of postural control. The most common method used to record displacement
of the center of pressure is called dynamic posturography, which involves subjects
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standing on a force measuring platform. Two common parameters tested are postural
sway and LOS.
Motor and sensory systems are essential to postural control. Motor components
of balance include, for example, organization of muscles into neuromuscular synergies
and righting and equilibrium reactions. The three primary peripheral sensory inputs
contributing to postural control are bilateral receptors of the somatosensory, visual and
vestibular systems. Somatosensation is the dominant sense for upright postural control
and is responsible for initiating automatic postural reactions. Somatosensory receptors
located in skin, joints, ligaments, and muscles provide information about muscle length,
stretch, tension, and contraction, as well as pressure and joint position. The feet,
ankles, knees, hips, back, neck and eye muscles all provide sensory information useful
for maintenance of balance. Disease of, or damage to, any part of the peripheral
sensory receptors and peripheral nerves impairs the detection abilities of this system,
making sensory information unavailable for use in postural control which can affect
standing balance.
There is evidence that increased postural sway and decreased LOS are
indicative of balance impairment in individuals with disorders such as FA, chronic
alcoholism and diabetic peripheral neuropathy (Diener et al., 1984; Emam et al., 2009;
Mauritz et al., 1979; Sullivan et al., 2010). In normal, healthy individuals, there is a small
amount of body sway (movement of the COM around the BOS) in quiet standing. This is
called postural sway. Cerebellar damage typically results in increased standing postural
sway especially with eyes closed (Diener et al., 1984; Mauritz et al., 1979). Mauritz and
colleagues (1979) noted increased postural sway in individuals with cerebellar atrophy
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due to chronic alcoholism and they reported that the type of sway was specific to the
location of the primary cerebellar lesion. Subjects stood on a force platform which had
strain gauges at each corner to measure the displacement of the COP in the anteriorposterior and medial-lateral directions, first with eyes open then with eyes closed.
Individuals with anterior cerebellar lobe atrophy had increased COP movement in an
anterior-posterior direction only, while those with vestibulocerebellar involvement
showed postural sway in all directions (Mauritz et al., 1979). Another study confirmed
these results and found differing patterns of sway abnormality in five groups of subjects
with ataxia compared with healthy, control subjects (Diener et al., 1984). The postural
sway patterns were specific to the type of ataxia and the area of the cerebellum
involved. One group consisted of 8 individuals with FA, referred to as “a disorder of
spinocerebellar afferents,” who all had loss of vibration and position sense in the lower
extremities. The subjects with FA showed a stronger lateral postural sway component
as compared to those with anterior lobe atrophy who showed more anterior/posterior
sway (Diener et al., 1984). Both groups showed a strong reliance on vision to maintain
their balance.

Another study by Diener and colleagues (1984) demonstrated that

people with FA, who had degeneration of spinocerebellar pathways, had a significantly
increased latency of EMG responses in the tibialis anterior muscle following a forward
perturbation of the force platform on which they were standing. The tibialis anterior
muscle should contract eccentrically to control the backward movement of the body as
the force platform moves forward (Horak et al., 1994; 1989). However, the individuals
with FA were unable to control the backward movement of their body as the platform
moved forward.
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People with chronic alcoholism exhibit peripheral neuropathy and cerebellar
vermian volume loss, which contribute to their balance deficits and gait ataxia even after
months of sobriety. Alcoholic women exhibited greater postural sway path length than
control subjects and sway in the anterior-posterior direction was greater than in the
medial-lateral direction (Sullivan et al., 2010). Despite significant postural sway in
alcoholics, they can use visual and tactile cues and stance stabilizing conditions to
significantly lesson their postural sway (Sullivan et al., 2006, 2010). People with diabetic
sensory neuropathy show poor postural control and are at a much higher risk to fall.
This has been attributed to their lack of accurate proprioceptive feedback from the lower
limbs (Emam et al., 2009). Emam and colleagues (2009) evaluated postural stability
using dynamic posturography in a group of Type 2 diabetics with peripheral neuropathy
compared to a group of diabetics without neuropathy. They concluded that postural
instability in diabetics with peripheral neuropathy reflects impairment of the
somatosensory system and that early detection of imbalance may predict and help
prevent falls in people with lower extremity somatosensory loss. People with FA have
somatosensory and proprioceptive deficits due to involvement of peripheral nerves, the
dorsal root ganglia and the spinal cord, which may contribute to increased postural
sway in standing and subsequent balance deficits.
Any given base of support puts limits on the distance a person’s body can move
without either falling (as COG exceeds BOS) or establishing a new BOS by stepping
with one foot (to relocate BOS under COG). This perimeter is often called the LOS.
Limits of stability has been defined as “the farthest distance in any direction a person
can lean (away from midline) without altering their original BOS by taking a step,
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reaching with outstretched arm or falling” (Umphred, 2007). Mohan and colleagues
(2009) used the Biodex Balance System SD (Biodex Medical Systems, Inc., NY) to
assess postural stability and LOS in people with spinocerebellar ataxia type 1 (SCA1).
Postural stability was assessed by testing subject ability to control balance in all
directions [Overall Stability Index (OSI)], front to back [Anterior-Posterior Index (API)],
and side to side [Medial-Lateral Index (MLI)]; and their ability to control LOS in all
directions. Impaired balance was found in 80% of people with SCA1 (all indices were
impaired in 35% of subjects, OSI and API in 25%, only OSI in 15%, and OSI plus MLI in
just 5%). Compared to controls, people with SCA1 had significantly higher postural
stability indices and lower LOS scores, indicative of worse balance. The mean value of
API was significantly higher than MLI. Only 14 of 20 subjects with SCA were able to
complete the LOS task and those who did took significantly longer to complete the task
and had significantly lower scores than controls. These authors also reported that all
balance indices were significantly correlated with ICARS scores.

Gait in Ataxia
Balance deficits, including increased postural sway and decreased LOS, have
been shown to be related to gait ataxia (Morton et al., 2003; Morton et al., 2004, 2007).
Worsening gait ataxia can contribute to falls and loss of functional ambulation. Morton
and Bastian (2003) found that subjects with severe balance deficits but without leg
coordination deficits demonstrated all of the classic features of gait ataxia including
decreased gait velocity and stride length, increased stride width, increased variability in
foot placement, and increased stride to stride variability in joint angles as compared with
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subjects who had primarily leg placement deficits. These authors concluded that
balance deficits contribute much more strongly to gait ataxia than lower extremity
incoordination (Morton et al., 2003; Morton et al., 2004, 2007).
Cerebellar ataxic gait is characterized by unsteadiness, staggering, a veering
path of movement, variable foot placement, and abnormal inter-joint coordination
patterns (Morton et al., 2004). This gait pattern, a hallmark of ataxia, has been widely
studied and described (Earhart et al., 2001; Ilg et al., 2007; Morton et al., 2003; Morton
et al., 2004, 2007; Palliyath et al., 1998). Ataxic gait has been studied quantitatively
using motion analysis systems, stride analyzers and more recently using the GAITRite
Walkway System (CIR Systems, Inc., PA). Palliyath and colleagues (1998) studied the
gait pattern of 10 subjects with cerebellar degeneration compared with 10 healthy,
control subjects using a five-camera, kinematic and kinetic data acquisition system. This
type of motion analysis provides detailed information about joint motion and forces of
the body during walking, yet, the equipment is costly and data collection is time
consuming. The GAITRite Walkway system is a valid and reliable tool used to measure
spatial and temporal parameters of gait (Bilney et al., 2003). This system has been
tested for reliability in neurological conditions including Parkinson’s disease,
Huntington’s disease, stroke and cerebral palsy (Kuys et al., 2011; Nelson et al., 2002;
Rao et al., 2005; Wondra et al., 2007).

The GAITRite Walkway system allows for

determination of gait parameters such as velocity, cadence, step and stride length, and
percent of the gait cycle in single and double limb support, yet, the system is portable
and the data can be collected in a relatively short period of time.
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Walking speed, also called gait velocity, is a valid, reliable, sensitive and specific
measure that correlates with balance, functional abilities and falls risk (Fritz et al.,
2009). Individuals with FA often lose the ability to walk in early adulthood and declining
gait velocity may predict functional decline. But why is gait speed a good predictor of
function? Walking is a complex task requiring significant energy. Many variables can
affect a person’s walking speed including motor control, muscle strength, sensation and
endurance. Additionally, walking places demands on many body systems including the
heart, lungs, circulatory, nervous and musculoskeletal systems (Studenski et al., 2011).
People with FA show involvement of many of these systems and the disease affects
energy production at the cellular level. Community ambulation involves more than how
fast a person walks. Decreased step and stride length are also seen in ataxic gait and
contribute to decreased gait velocity (Earhart et al., 2001; Ilg et al., 2007; Morton et al.,
2003; Palliyath et al., 1998). People with FA have balance and coordination problems
that predispose them to falls. They may limit their step length and limit community
ambulation or use a wheelchair to avoid falls which will secondarily affect their
endurance.
Gait variability has also been well documented in ataxia and is related to
functional walking impairment (Ilg et al., 2007; Morton et al., 2003; Palliyath et al.,
1998). Palliyath and colleagues (1998) found that subjects with cerebellar degeneration
showed significantly reduced step and stride lengths and a trend toward decreased
cadence which both contributed to slower gait velocities. Subjects with ataxia showed
significant variability of nearly all gait parameters including step and stride length,
cadence, step time and stance time. These authors concluded that although gait
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variability is characteristic of movement disorders, it is particularly marked in cerebellar
dysfunction. Stolze (2002) analyzed gait ataxia in twelve subjects with cerebellar
disease of various causes compared to twelve age-matched controls using a motor
driven treadmill and motion analysis. They reported significantly reduced step frequency
with prolonged stance and double limb support duration in the people with cerebellar
disease. Most gait parameters were found to be highly variable in this population and
the balance related variables such as step width and foot rotation angle were increased
in the cerebellar group indicating a need for stability during locomotion. Cadence was
reduced as a result of increased stance and double limb support duration, which may
have been another compensation developed to make walking more stable (Stolze et al.,
2002).
Researchers investigated the effect of different types of cerebellar dysfunction on
the gait pattern of people with cerebellar degeneration using motion analysis and the
ICARS (Ilg et al., 2007). They found significant differences between subjects with
cerebellar degeneration and healthy controls in several gait parameters including step
length, step width, gait velocity and step length variability. Consistent with other studies
(Morton et al., 2003; Palliyath et al., 1998; Stolze et al., 2002), Ilg et al. (2007) found a
high correlation between balance related gait parameters and balance deficits as
measured by a subscore of the ICARS clinical rating scale. Additionally, a comparison
of gait measures between three groups of subjects with different movement disorders
(cerebellar degeneration, Parkinson’s disease and peripheral vestibular disease),
indicated that increased temporal variability of intra-limb coordination patterns was
specific to cerebellar degeneration and not an indirect consequence of balance
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problems. Morton and colleagues (2010) conducted a one year longitudinal study of gait
and balance changes in eighteen subjects with mixed cerebellar disorders including
tumor, stroke and degenerative disease using motion analysis, a balance force plate
and the ICARS test. Subjects were assigned to three groups: a group with static,
unchanging cerebellar lesions; a degenerative cerebellar group; and a healthy, control
group. There were significant differences in postural sway and gait parameters
(including stride length, stride width, cadence, stance time, double-support time and gait
velocity) between the cerebellar groups and the control group. Neither cerebellar group
demonstrated significant changes in postural sway, sway variance or dynamic weight
shifting over one year. However, over time, the static group tended to walk faster and
take longer strides while the degenerative group walked slower and took shorter strides.
There was a significant worsening of ICARS scores in the degenerative group over one
year as compared to the other two groups. These researchers concluded that the
ICARS test was sensitive to increases in ataxia severity occurring over time and it
correlated well with the instrumented measures of gait (Morton et al., 2010).
Less well understood is the gait pattern of individuals with a sensory ataxia such
as FA. Croarkin and Maring (2009) described gait parameters in 38 children and
adolescents with FA and examined the relationship between disease severity, as
measured by the FARS test, and gait parameters. Spatiotemporal gait parameters were
collected using a computerized footswitch system and compared with age-matched
normative data. Adolescents and children with FA showed significantly slower gait
velocity, reduced cadence and shorter stride lengths compared with children without
disabilities. These gait parameters were strongly correlated with FARS scores and the

27

scores were predictive of the children’s level of walking ability. Serrao and colleagues
(2012) studied the gait pattern of 8 subjects with SCA and 8 with FA using motion
analysis and force plates to record kinematic and kinetic data, respectively. They found
a marked difference in all gait parameters between subjects with ataxia and healthy
controls. They also reported a strong correlation between stride length and stance
duration and ICARS scores (gait, posture and total scores). Both ataxic groups
demonstrated wide based walking with increased double support time, increased stance
duration, decreased step length and decreased gait velocity compared with healthy
controls. People with FA exhibited shorter step lengths than those with SCA. For almost
all gait parameters, there was significant intra-subject gait variability in those with ataxia
compared to controls, which was strongly correlated with ICARS scores. Other
researchers evaluated gait variability in 31 subjects with FA across age groups using a
gait variability index (GVI) and reported the GVI to be significantly lower in the FA group
compared to the control group, indicative of greater variability (Gouelle et al., 2013).
Ilg and colleagues (2009) examined the effectiveness of a four week intensive
coordination training program for 16 patients with progressive ataxia due to either
cerebellar degeneration (n=10) or degeneration of afferent pathways (n=6). This latter
group with sensory ataxia included 3 people with FA. The primary outcome measures
included the SARA, ICARS, BBS, subject perceived goal attainment and quantitative
balance and gait analysis using an 8 camera motion analysis system. They examined
gait velocity, step length, step width, lateral body sway and temporal variability of intralimb coordination during walking. They also determined body sway in standing by
measuring movement of the COG during a static and a dynamic balance task. Four
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assessments were performed at 8 weeks before, immediately before, directly after and
8 weeks after training. The results revealed a significant decrease in ataxia symptoms
for all subjects as measured by the SARA following a 4 week coordination training
program. Patients with predominantly cerebellar ataxia showed a more distinct
improvement than those with sensory ataxia in gait velocity, lateral body sway, intralimb
coordination and static and dynamic balance tasks. Follow-up assessment at 8 weeks
showed retention of improvement in the cerebellar group but not the afferent group for
all tasks except the dynamic balance task. Ilg and colleagues (2010) went on to assess
the same subjects one year after the 4 week intensive coordination training program.
Despite a gradual decrease in motor performance and increase in ataxia due to disease
progression in both patient groups, improvements in motor performance and ADL
persisted after 1 year in the cerebellar group after 4 weeks of intensive coordination
training. For the afferent group, the improvement in ataxia symptoms were less
pronounced and did not persist at 1 year follow-up.

Summary
In summary, research investigating FA balance and gait is very limited. One
study characterized gait patterns in children and adolescents with FA (Croarkin et al.,
2009). Two studies investigated gait in subjects with FA across age groups; one
comparing gait in people with FA to that of SCA, while a second study focused on the
use of a gait variability index (Serrao et al., 2012; Gouelle et al., 2013). Most research
studies of balance and gait in ataxia use cross sectional research designs and clinical
rating scales, such as the ICARS, FARS and SARA, but these scales are subject to
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bias. Although these clinical rating scales are widely used, they do not quantitatively
identify balance deficits and gait deviations characteristic of ataxia. Some cross
sectional studies have used force platforms and motion analysis to quantitatively
measure balance and gait, respectively. Cross sectional studies cannot measure
change in balance and gait over time as is possible with a longitudinal research design.
To our knowledge, only one longitudinal, natural history study has investigated change
in balance and gait over time, but this study included people with mixed cerebellar
disorders and no subjects with FA (Morton et al., 2010). Recently, quantitative tools
such as the Biodex Balance System SD (Biodex Medical Systems, Inc., NY) and the
GAITRite Walkway System (CIR Systems, Inc., PA) have become available to
objectively assess balance and gait, respectively. Studies using clinical rating scales
have shown that 1 to 2 years is not long enough to show minimally important
differences in FA disease progression (Cano et al., 2005; Ribai et al., 2007). It is
possible that quantitative measures of gait and balance could show more subtle
changes in shorter periods of time.
Quantitative analysis of FA balance and gait is quite limited, with no study
investigating the natural history and progression of both balance and gait deficits in
adults over time. Little evidence exists as to which methods are most sensitive for
tracking the progression of FA balance and gait, but this information is critical for
assessing the effectiveness of current and newly developing treatments. Such
information is also important to plan and assess the efficacy of rehabilitation strategies
and to predict risk of falls and future level of walking ability.
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The purpose of the present study was to characterize the gait pattern of adults
with FA and to determine whether gait parameters change over 24 months. This study
also investigated whether postural control; postural stability and limits of stability, and
BBS scores change over 24 months in this patient cohort. Finally, the study investigated
the relationship between disease duration, clinical rating scale scores and objective
measures of gait and balance.
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CHAPTER TWO
METHODS

Research Design
This study used a longitudinal research design to investigate changes in balance
and gait over time in adults with FA. The study and all research procedures conducted
as part of this study were approved by the University of South Florida (USF) Institutional
Review Board (#Pro00001687).

Study Participants
Subjects for this study included eight adults with genetically confirmed FA and
eight healthy, matched controls. Control subjects were matched based on gender, age,
height and weight and had no history of neurodegenerative or musculoskeletal disease
that would affect their gait or balance. The criteria used to match controls to cases were
pre-established within the following parameters: same gender, age (±3 years), height
(±5 cm) and weight (±10 kg).

All subjects gave informed consent using an IRB

approved consent form prior to participation in this study. Subjects with FA were
recruited from the USF Neurology clinics, from local and state ataxia support groups,
and nationally from the Friedreich’s Ataxia Research Alliance (FARA). Control subjects
were recruited from among the students, faculty and staff of USF Health and from the
community.
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Inclusion and Exclusion Criteria
The following criteria were met for subjects to participate in this study: diagnosis
of FA confirmed by genetic testing (cases only); subjects between 18 and 50 years of
age; subjects must be taking stable doses of all prescription and over-the-counter
medications for 30 days prior to study entry and for the duration of the study; subjects
could not enroll in any drug or other intervention trials during the course of this study;
and subjects had to be able to ambulate with or without an assistive device for at least
30 feet and maintain stable levels of physical activity and exercise.
The following criteria excluded subjects from participating in this study: presence
of neurodegenerative disease (controls only); presence of any condition resulting in a
disturbance of gait or balance (controls only); any unstable illness that in the
investigator’s opinion precluded participation in this study such as advanced
cardiopulmonary disease, dementia or other psychiatric illness; legal incapacity or
limited legal capacity; or women who were pregnant or breast feeding.

Study Procedures
All subjects received a comprehensive examination in the USF Department of
Neurology which included history, neurological examination and the FARS. Gait and
balance were tested quantitatively using equipment in the USF School of Physical
Therapy and Rehabilitation Sciences Human Functional Performance Laboratory. This
equipment allowed for serial objective measurement of gait and balance parameters.
The Berg Balance Scale (BBS) was conducted to assess static and dynamic balance.
Subjects with FA underwent evaluation of gait and balance and clinical rating scales at
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baseline, 6 month, 12 month and 24 month follow-up. Matched control subjects
underwent the same testing, but only at baseline and 12 months.

Clinical Rating Scales
All subjects rated their perceived exertion (RPE) (Borg et al., 1982) and vital
signs (blood pressure and pulse) were measured and recorded immediately before and
after gait and balance tests. The Borg RPE Scale uses a psychophysiologic approach in
which the exerciser rates their feelings of perceived exertion related to strain, discomfort
and/or fatigue experienced during aerobic or resistance exercise. The RPE scale is a
numerical scale from 6 to 20 in which 6 equals no exertion at all while 20 equals
maximal exertion. Subjects were rated by a neurologist on the FARS, a test of disease
severity using an ordinal rating scale. The neurological exam subscale measures bulbar
and speech function, upper and lower extremity coordination, peripheral neuropathy,
and upright stability. Lower extremity sensory testing was conducted as part of the
neurological exam. Subjects were also assessed by a physical therapist on the BBS, a
valid and reliable test of static and dynamic balance consisting of 14 tasks (Berg et al.,
1992). This balance scale requires participants to perform various tasks in sitting and
standing, for example, sit to stand, standing unsupported, and reaching with
outstretched hand while standing. Each item is graded on an ordinal scale from 0-4 with
a maximum total score of 56. People who score below 45 out of 56 are considered at
greater risk to fall (Berg et al., 1992).

34

Gait Testing Procedures
Spatiotemporal gait parameters were quantified using the GAITRite Walkway
System (Figure 2). This system is a computer based instrumented walkway developed
to measure gait and includes a 26 foot long by 3 foot wide mat (7.93 X 0.91 meters)
which resembles a carpet runner. An extensive array of electronic pressure-activated
sensors is imbedded in the 1/8” thick mat between a carpet layer on top and foam
rubber on the bottom. The sensors are arranged in a grid pattern and placed 1.27 cm
apart with a total of approximately 14,000 sensors. These sensors are activated by
mechanical pressure at foot contact as the person walks down the mat. Data is sampled
from the mat at a frequency of 80 Hz. Data are collected from activated sensors by a
series of processors (located on one side of the mat) and uploaded to a laptop
computer through a serial port. Dedicated GAITRite application software (Version 4.7)
converts the raw data into footfall patterns and computes temporal parameters such as
gait velocity or time in double limb support, and spatial parameters such as step and
stride length. The software program calculates gait parameters for each footstep of
each walking trial as well as an overall average of all trials for each parameter. The
following gait parameters were evaluated in this study: gait velocity (m/s), cadence
(steps/min), step length (cm), stride length (cm), step and stride length variability (cm)
and percent of the gait cycle in swing, stance and double limb support.
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Figure 2. GAITRite Walkway System
Photos courtesy of GAITRite Walkway Systems, Inc.
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Subjects were allowed to walk down the GAITRite mat using their usual gait
assistive device. The data processing software eliminated strikes from assistive devices
so that only footstep data was saved. Walking performance was recorded using a digital
videocamera, which was set up on a tripod approximately 6 feet from the end of the mat
to capture each subject’s walking trials for the entire length of the walkway. The video
was used to verify subject identity, assistive device use, level of assist required to walk
and to verify walking parameters related to data processing. The video was also used
along with the software to confirm the number of footsteps in each trial and that the
footsteps were completely on the mat. Data generated from each trial was checked to
assure that this trial represented gait performance consistent with other trials in the
same test.
The height, weight and bilateral leg length for each subject were measured prior
to baseline gait testing. Subject leg length was measured as the distance (in cm) from
the greater trochanter to the floor bisecting the lateral malleolus. This information was
entered into the computer to enable the GAITRite software to calculate gait parameters.
The subjects were asked to walk along the 26 foot long walkway for five trials at their
comfortable, self-selected walking speed. They were then asked to walk at their fastest
possible speed with verbal instruction to “walk as fast as you can.” The comfortable and
fast walking trials were each preceded by one practice trial. Subjects began walking
about 2 meters before the mat and continued walking about 2 meters past the end of
the mat. This assured that they walked at a consistent speed along the instrumented
section of the mat. Subjects were encouraged to wear the same (or similar) pair of flat
soled shoes for each testing session. The subjects were supervised closely by a
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licensed physical therapist during walking tests. Each subject wore a gait belt so that
the therapist could grasp hold of them in the event of a loss of balance while walking.

Gait Data Processing
While all spatiotemporal gait parameters captured by the GAITRite Walkway
System were collected, processed and analyzed, the focus of data analysis was on gait
velocity, cadence, step and stride length, step and stride length variability and percent
of the gait cycle spent in swing and stance phase and double limb support. Gait velocity
was calculated by dividing the distance walked by the ambulation time expressed in
m/s. Ambulation time is the time elapsed in seconds between the first contact of the first
footfall to first contact of the last footfall on the mat. The GAITRite software forms a
quadrilateral shape around each footprint for each walk and uses this information to
calculate the heel center of each footprint. The line of progression is the line connecting
the heel centers of two consecutive footfalls of the same foot. Step length was
measured on the horizontal axis of the GAITRite walkway from the heel center of one
footprint to the previous footprint of the opposite foot expressed in cm. Stride length was
measured on the line of progression from the heel centers of two consecutive footprints
of the same foot expressed in cm. Variability of step and stride lengths were determined
by calculating standard deviation of step or stride length over the five trials for
comfortable and fast walking separately. Variability was calculated as the standard
deviation of step or stride length utilizing the formula:
√

∑(
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Following each walking trial, data were uploaded to the computer and automatic
footstep identification and gait parameter calculations were made by the GAITRite
software. The GAITRite system automatically provided quantitative data about the
subject’s walking, however, it also allowed for manual processing of footprints. In this
study, each footprint and walk was manually processed to assure accuracy and
consistency of gait data within and across subjects. To manually process the gait data,
each footprint was identified and separated from the other footprints in the same walk.
Incomplete footprints at the beginning or end of each walk were removed from the walk.
Strikes from gait assistive devices or foot scuffs were removed from the walk. Left and
right footprints were delineated and all footprints separated from each other. Once this
manual gait data processing was completed, the GAITRite software re-calculated all
gait parameters and the data for each walk were saved. The data from each walk and
the averaged data across five trials for both comfortable and fast walking were exported
to an excel spreadsheet for further analysis.

Balance Testing Procedures
Subject balance was examined utilizing the Biodex Balance System SD which is
an instrumented platform developed as a testing and training device appropriate for
individuals with neuromusculoskeletal disorders (Figure 3). The Biodex Balance System
SD (Biodex SD) consists of a suspended circular platform with four built-in strain gauge
type pressure sensors, one in each of four quadrants of the platform. This strain gauge
technology allows the Biodex SD to detect weight distribution of the subject as they
stand or sway on the platform. The degree of platform surface instability is controlled by
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a microprocessor-based actuator; however, for this study the platform remained in the
locked or static setting for all tests. The platform is connected to computer software
(Biodex Version 3.1, Biodex Medical Systems, NY) which allows the device to be used
objectively in posturography. Prior to beginning testing, the age and height category for
each subject were entered. Subjects were asked to stand comfortably on the platform
with arms at their sides such that foot placement could be established. A cursor, which
represents the real time location of the subject’s center of pressure, appeared on the
visual display. The researcher adjusted the position of the subject’s feet until both feet
were equidistant from the center of the platform and the cursor remained at the center
of a series of concentric circles (target). Once the feet were positioned on the platform,
tape was placed around each foot so that the feet could be repositioned easily should
the subject move them during testing. Foot placement data were recorded to insure
consistency for each test and consistency of foot placement in subsequent follow-up
testing.
The Biodex SD was used for measurement of postural stability and LOS. Two
postural stability tests were conducted which are indicative of postural sway. The first
involved the subject standing quietly with eyes open and hands at their sides, while the
second involved quiet standing with eyes closed. Subjects were not allowed to view the
monitor during postural stability tests and three 30 second trials of each test were
preceded by one practice trial.
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Figure 3. Biodex Balance System SD
Photos courtesy of Biodex Medical Systems, Inc.
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Subjects performed three trials of the LOS test and were allowed to view the
monitor during this test. For the LOS test, subjects were asked to shift their center of
pressure to eight targets positioned in an elipse without changing foot position. During
each trial, subjects shifted their weight to move the cursor from the center target to a
peripheral blinking target and back to center as quickly but as accurately as possible.
This process was repeated for each of nine peripheral targets which were set to blink in
random order. During all tests on the balance platform, subjects wore a gait belt and
were supervised by two physical therapists. Subjects were allowed to hold onto the
handrail only to prevent a fall.

Balance Data Processing
The balance parameters generated by the Biodex SD for the two postural
stability tests (quiet standing with eyes open and quiet standing with eyes closed)
included an Overall Stability Index (OSI), an Anterior/Posterior Stability Index (API), and
a Medial/Lateral Stability Index (MLI). The Biodex SD calculated these parameters as
indicative of postural sway. Postural sway is commonly measured by recording
displacement of Center of Pressure (COP) on a force measuring platform
(posturography). The objective of the postural stability tests is to quantitatively
determine a score representing a subject’s ability to maintain a stable vertical posture or
position on the stationary platform under varying sensory conditions; either eyes open
or eyes closed.
Subjects stood on the static force measuring platform. The platform contains four
strain gauge type pressure sensors; one in each of four quadrants. The static balance
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platform sampled and recorded subject COP movement continually at a sampling rate
of 20 Hz. The strain gauge sensors detected forces applied downward in each of 4
quadrants during subject movement in quiet standing. The sensors measured
displacement of the subject’s center of pressure in an anterior/posterior and
medial/lateral direction as a measure of postural sway. For example, during increased
postural sway in an anterior direction, increased force is applied by the subject in the
anterior quadrant of the platform. The Biodex SD uses this information to calculate
movement of the COP anteriorly to calculate API. The COP is the subject’s center of
gravity (COG) projection on the platform resulting from sway angle and patient height.
Each recorded sample consisted of an (x, y) coordinate. The sway angle was derived
from the displacement of the COG from zero and the subject’s height with COG taken
as .55 of each subject’s height. The OSI, API and MLI indices represent measures of
variance (standard deviation) which were assessed from movement of subject COG
along a sway path around a zero point representing the center of the platform.
Displacement of the COG that occurs along the medial/lateral axis is labeled as xdirection, while that on anterior/posterior axis is labeled as y-direction and these
variables are used to generate the MLI and API. The OSI, which is sensitive to change
in body sway in both the M/L and A/P direction was derived from the following formula:
√∑(

)

∑(

)

The balance parameters generated by the Biodex SD for the LOS Test included
an Overall Directional Control Score, time to complete the test, and directional control
scores for forward, backward, left, right, and combination directions such as forward and
to the left. Limits of stability are defined as the maximum angle a person’s body can
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lean away from the vertical without losing balance. Once the LOS is exceeded, a
corrective strategy like a step must occur to prevent the person from falling. LOS for
bilateral stance in normal adults is 8 degrees anterior, 4 degrees posterior and 16
degrees in a lateral direction. The LOS test challenges subjects to control their COG
within their base of support. During each trial, subjects must shift their weight to move
the cursor from a center target to a blinking target and back to center as quickly and
with as little deviation as possible. This same process is repeated for each of 8
peripheral targets and these targets blink red in random order. One parameter
calculated by the Biodex SD for the LOS test is time, i.e., how long it takes the subject
to move the cursor to all 8 peripheral targets and back to the center. The static (nonmovable) platform is used to record subject’s movement of their COG over their base of
support as an average amount of angular displacement of the COG defined as a
percentage of the LOS. The Biodex SD calculates the directional control scores by
dividing the straight line distance from the center target to the peripheral target (in cm)
by the actual distance traveled (in cm) multiplied by 100 to generate a percentage
score.
Directional Control Score (%) = straight line distance to target X100
actual distance traveled
The overall directional control score for the LOS Test was calculated as an average of
the directional control scores to all 8 targets. This represents an overall LOS score for
the subject on this test.
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Data Analysis
Subject demographic characteristics and all gait and balance measures were
summarized using means and either standard deviations or standard error.
Demographic, gait and balance data were tested for normality using the Shapiro-Wilk
test. Baseline gait and balance measures were compared between subjects with FA
and normal, healthy controls. In addition, gait and balance parameters were analyzed to
identify longitudinal changes in performance for subjects with FA from baseline to 6, 12
and 24 months. Control subject baseline and twelve month data were used as a normal
comparison. Statistical analyses were conducted utilizing the Statistical Package for
Social Sciences version 22.0 (SPSS; IBM Corp; Armonk, NY) and SAS version 9.3
(SAS Institute, Cary, NC). Paired t-tests were conducted to determine if there was a
significant difference between FA and control subjects in gait and balance parameters
and clinical rating scale scores at baseline. Paired t-tests were also conducted to
assess for differences in control gait and balance measures from baseline to 12 months.
When a variable’s distribution showed evidence of non-normality, the Wilcoxon Signed
Rank test was applied in place of the paired t-test.
Repeated measures analysis of variance (ANOVA) was performed to test mean
differences in gait and balance data for subjects with FA across three sessions of
assessments (baseline, 6 month, and 12 month follow-up). The critical assumption of
repeated measures ANOVA, sphericity, was tested using Mauchly’s method. Because
this assumption was violated for several variables and due to missing data for one
subject at the 24 month testing session, a linear mixed effect model was applied to FA
subject data from baseline to 24 months.
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Pearson’s Correlation Coefficients were assessed to determine whether there
were significant linear correlations between age, disease duration, years since FA
diagnosis and gait and balance parameters at baseline and at 24 months. Spearman’s
correlation coefficients were assessed to determine whether there were significant
correlations between BBS and FARS scores (total and upright stability scores) and gait
and balance parameters at baseline and at 24 months. Additionally, Pearson’s
correlations were assessed to determine the strength of the linear association between
quantitative balance and gait parameters at both time points. All statistical tests were
two sided with significance level set at p<0.05.
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CHAPTER THREE
RESULTS

Demographic and Clinical Characteristics
Subject demographic and clinical data are summarized in Table 1. Subject
demographic data (age, height, and weight) were measured at baseline. There were no
significant differences in mean age, height or weight between adults with FA and their
matched controls as determined using paired t-tests (p>0.05). Six FA subjects had
symptom onset during adolescence, whereas the remaining two had symptom onset
during adulthood, thus they had a type of FA referred to as late onset FA (LOFA). All 8
control subjects completed baseline and 12 month testing sessions, whereas 7 subjects
with FA completed baseline, 6 month, 12 month and 24 month testing sessions, and 1
FA subject failed to complete the 24 month testing session. Disease duration among FA
subjects varied from 6 to 16 years with an average of 10 years. Two subjects with FA
used an assistive device for household and community ambulation, while 3 others used
a device for community ambulation only. The FA subject with longest disease duration
(16 years) was the only one who required a walker during gait testing. No subjects with
FA wore lower extremity orthotics.
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Table 1. Demographic and Clinical Characteristics
FARS
Total
Scores
66

Age at
symptom
FA onset

Age at
Diagnosis

Disease
Duration
(years)

Genetic
Repeats

56.7

BBS
Scores
14

18

19

16

850/1000

154.9

56.7

45

40

13

17

8

933/800

25

172.7

70.3

45

42.5

15

19

10

500/900

M

25

175.3

101.2

46

42.5

15

19

10

500/900

F5

M

23

180.3

61.7

44

33

15

15

8

892/533

F6

M

43

185.4

80.7

50

45

28

30

15

1067/18

F7

M

42

187.9

106.6

53

29

36

39

6

1000/166

F8

M

22

185.4

72.6

51

35.5

16

19

6

*

29.4 (9.0)

174.3 (13.8)

75.8 (19.2)

43.5 (12.4)

41.7 (11.2)

19.5 (8.1)

22.1 (8.1)

9.9 (3.8)

Subjects
with FA

Sex

Age
(years)

Height
(cm)

Weight
(kg)

F1

F

34

152.4

F2

F

21

F3

M

F4

Mean (sd)
Control
Subjects
C1

F

37

154.9

56.7

56

1

C2

F

23

154.9

56.3

56

0

C3

M

25

172.7

70.3

56

0

C4

M

24

177.8

95.3

56

0

C5

M

22

177.8

72.6

56

0

C6

M

43

185.4

75.8

56

0

C7

M

41

182.9

104.3

56

0

C8

M

22

185.4

70.3

56

2

29.6 (9.1)

174.0 (12.5)

75.2 (19)

56 (0)

0.38 (0.7)

Mean (sd)

Subject demographic data (age, height, weight) and clinical characteristics were determined at baseline. Disease duration
is defined as the time from symptom onset to enrollment in the study. *Genetic information for subject F8 indicated 200400 repeats on one allele, with the number of repeats on the other allele within the normal range.
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Baseline Comparisons between FA and Control Subjects
As expected, at baseline, there were significant differences in all gait and
balance parameters and clinical rating scale scores between subjects with FA and their
matched controls as determined using paired t-tests (p<0.05). All measures were tested
and found to be normally distributed using the Shapiro-Wilk test.

Clinical Rating Scales
Berg Balance Scale scores are presented in Table 1. All control subjects
achieved the maximum score of 56 on the BBS assessment. One FA subject received a
score of 14, while values for the other 7 FA subjects ranged from 44 to 53. Thus,
subjects with FA exhibited significantly lower scores than controls (p<0.05). Two FA
subjects had BBS scores of 14 and 44 at baseline which fell below the cut-off score of
45 considered indicative of falls risk.
FARS total scores, also shown in Table 1, differed significantly between subjects
with FA and healthy controls at baseline as determined using paired t-tests (t=10.54,
p<0.001). In addition, FARS upright stability scores were significantly different between
groups (t=13.96, P<0.001). The control subjects had near perfect FARS total scores
and perfect upright stability scores of zero at baseline. In contrast, subjects with FA had
mean FARS total scores of 41.7 with a range from 29 to 66 and mean upright stability
scores of 24.9 with a range from 19 to 33. The FARS scores of the FA cohort are
indicative of ataxia symptoms and the range of scores indicate the heterogeneity of the
sample.

49

Gait
Table 2 summarizes baseline gait parameters for the FA and control groups. Gait
velocity in the FA group was approximately 50% slower than the control group during
both comfortable and fast walking (p<0.001). Cadence was reduced by 30% for
comfortable walking and 35% for fast walking (p<0.01), while step and stride lengths
were 32% shorter in the FA group compared to controls during both comfortable and
fast walking (p<0.001). Step and stride length variability were 3.5- and 2.7-fold greater
(p<0.01) for subjects with FA than for controls during comfortable and fast walking,
respectively.
There was a significant difference between FA and control groups in percent of
the gait cycle (GC) spent in swing, stance and double limb support for both comfortable
and fast walking at baseline. Controls spent 39% of the GC in swing phase and 61% in
stance phase during comfortable walking, whereas subjects with FA spent less time in
swing phase (34% of GC) and more time in stance phase (66% of GC), differences that
were significant (p<0.01). Similarly, during fast walking, controls spent 42% of the GC in
swing phase and 58% in stance phase, while subjects with FA spent 38% of the GC in
swing phase and 62% of the GC in stance phase (p<0.01). In addition, subjects with FA
exhibited a prolonged double limb support phase (31% and 23% of the GC during
comfortable and fast walking, respectively) compared with the control group (22% and
16% of the GC during comfortable and fast walking, respectively) (p<0.01).
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Table 2. Baseline Gait Parameters
FA

Control

p value

Velocity (m/s)

0.7 ± 0.1

1.4 ± 0.0

p<.001

Cadence (steps/min)

78.5 ± 7.2

112.4 ± 3.2

p=.009

Step Length (cm)

50.1 ± 4.6

73.9 ± 2.7

p<.001

Stride Length (cm)

100.6 ± 9.3

148.0 ± 5.4

p<.001

Step Length Variability (cm)

6.7 ± 3.2

1.9 ± 0.3

p=.003

Stride Length Variability (cm)

10.6 ± 1.9

3.1 ± 0.5

p=.003

Swing (% of gait cycle)

34.0 ± 1.2

39.2 ± 0.3

p=.004

Stance (% of gait cycle)

66.0 ± 1.2

60.9 ± 0.3

p=.004

Double Support (% of gait cycle)

31.3 ± 2.4

21.7 ± 0.7

p=.006

Velocity (m/s)

1.0 ± 0.1

2.1 ± 0.1

p<.001

Cadence (steps/min)

89.9 ± 7.2

138.3 ± 3.8

p=.001

Step Length (cm)

64.0 ± 4.6

93.7 ± 3.1

p<.001

Stride Length (cm)

128.5 ± 9.4

187.5 ± 6.2

p<.001

Step Length Variability (cm)

6.7 ± 1.0

2.5 ± 0.2

p=.003

Stride Length Variability (cm)

10.4 ± 1.6

3.9 ± 0.4

p=.004

Swing (% of gait cycle)

38.1 ± 0.7

42.2 ± 0.4

p<.001

Stance (% of gait cycle)

61.9 ± 0.7

57.8 ± 0.4

p<.001

Double Support (% of gait cycle)

22.9 ± 1.3

15.6 ± 0.9

P<.001

Comfortable Walking

Fast Walking

All values are expressed as means ± SEM. Paired t-tests were used to compare FA to
control groups at baseline.
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Balance
Table 3 summarizes postural stability indices for the FA and control groups.
Subjects with FA exhibited significantly higher postural stability indices (OSI, API and
MLI) than controls during quiet standing with eyes open (EO) (p<0.05) and with eyes
closed (EC) (p<0.01). Higher indices denote worse postural stability. The OSI with EO
and EC was 2.9- and 4.8-fold greater than control subjects at baseline, respectively.
The API with EO and EC was 2.6- and 4.5- fold greater, while MLI with EO and EC was
3.2- and 6.0-fold greater than controls, respectively. Additionally, postural stability
parameters in controls did not differ with EO or EC, whereas, in FA subjects these
parameters doubled with EC compared to EO.
Table 4 summarizes limits of stability parameters for the FA and control groups.
Of the 8 FA subjects tested, 1 was unable to perform the LOS test, and thus, this
individual and the corresponding control were removed from the LOS analysis. The
remaining individuals with FA required 72% more time to complete the LOS test than
controls (p<0.05). Further, these individuals had an overall directional control score of
35%, which was 50% less than controls (p<0.05). All LOS directional control scores
were significantly different between the two groups, with the exception of the left
directional control score (p=0.057). During performance of the LOS test, subjects with
FA exhibited undershooting and overshooting of the targets, as well as extraneous
movements.
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Table 3. Baseline Postural Stability
FA (n=8)

Controls (n=8)

p value

Eyes Open

2.9 ± 0.6

1.0 ± 0.2

p=.018

Eyes Closed

5.7 ± 0.9

1.2 ± 0.2

p=.003

Eyes Open

1.8 ± 0.4

0.7 ± 0.1

p=.039

Eyes Closed

3.6 ± 0.7

0.8 ± 0.3

p=.009

Eyes Open

1.9 ± 0.5

0.6 ± 0.1

p=.033

Eyes Closed

3.6 ± 0.6

0.6 ± 0.2

p=.005

Overall Stability Index (OSI)

Anterior Posterior Index (API)

Medial Lateral Index (MLI)

All values expressed as means ± SEM. Paired t-tests were used to compare FA to
control subjects at baseline.

Table 4. Baseline Limits of Stability
FA (n=7)

Controls (n=7)

p value

49.2 ± 3.4

28.6 ± 0.9

p=.001

Overall

34.5 ± 6.0

67.8 ± 4.8

p=.012

Forward

44.9 ± 6.6

70.2 ± 3.3

p=.010

Backward

47.6 ± 5.7

68.0 ± 5.8

p=.032

Right

49.7 ± 6.0

75.7 ± 5.9

p=.037

Left

45.0 ± 9.8

78.1 ± 6.1

p=.057

Forward Right

41.9 ± 4.5

65.0 ± 5.8

p=.041

Forward Left

38.6 ± 7.3

68.5 ± 5.5

p=.042

Backward Right

37.8 ± 7.5

73.6 ± 3.5

p=.011

Backward Left

35.6 ± 7.5

69.0 ± 5.4

p=.023

Time (sec)
Directional Control Score (%)

All values expressed as means ± SEM. Paired t-tests were used to compare FA to
control subjects at baseline.
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Correlations
To ascertain whether temporal demographic data, clinical rating scale scores and
gait and balance parameters were related at baseline, data from FA patients were
subjected to correlational analyses [Spearman’s (ρ) for BBS and FARS; Pearson’s (r)
for all other variables]. Results indicated no significant correlations between subjects’
age and gait or balance measures. Disease duration correlated with: FARS total scores
(r=.855, p=0.007); OSI with eyes open (r=.787, p=0.020); and MLI with eyes open
(r=.934, p=0.001. FARS total scores correlated with MLI with eyes open (ρ=.711,
p=0.048); but did not correlate with any other variables (p>0.05). Further, FARS upright
stability scores did not correlate with any variables (p>0.05).
Relationships between balance measures and gait parameters are shown in
Table 5. Berg Balance Scale scores correlated negatively with step length variability for
comfortable and fast walking (p<0.001) and with stride length variability for comfortable
and fast walking (p=0.007 and p=0.011, respectively), but did not correlate with any
other gait parameters (p>0.05). Although not shown in the table, the BBS also
correlated positively with the LOS right directional control scores (ρ=.883, p=0.008),
forward left directional control scores (ρ=.847, p=0.016) and the backward left
directional control scores (ρ=.883, p=0.008).
Quantitative balance parameters also correlated with gait parameters at baseline.
Although OSI with eyes open did not correlate with gait parameters, OSI with eyes
closed was positively correlated with stride length variability during fast walking
(p=0.47). The API with eyes open correlated only with step length variability during
comfortable walking (p=0.037). In contrast, API with eyes closed correlated only with
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stride length variability during fast walking (p=0.044). The MLI with eyes open was not
associated with any gait parameters. The MLI with eyes closed did not correlate with
gait variability, but did correlate with percent of the gait cycle in swing, stance and
double limb support for comfortable walking (p=0.022, p=0.023 and p=0.018,
respectively).
Time to complete the LOS test correlated with step length variability for
comfortable and fast walking (p=0.004 and p=0.020, respectively) and with stride length
variability for comfortable and fast walking (p=0.002 and p=0.017, respectively). Finally,
the LOS overall directional control scores correlated negatively with step length
variability for comfortable and fast walking (p=0.035 and p=0.017, respectively) and with
stride length variability during comfortable and fast walking (p=0.036 and p=0.014,
respectively). No other objective balance parameters were associated with gait
parameters at baseline (p>0.05).

Longitudinal Changes in Gait

Gait Velocity and Cadence
The mean gait velocity and cadence over 12 months for controls and over 24
months for FA subjects are shown in Figure 4. There were no significant changes in
these parameters from baseline to 12 months for controls as determined using paired ttests (p>0.05). In subjects with FA, gait velocity declined by 25% and 30%, while
.
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Table 5. Relationship between Balance Measures and Gait Parameters

Berg
Balance
Scale
Scores

Postural Stability

Limits of Stability

OSI
Eyes
Open

OSI
Eyes
Closed

API
Eyes
Open

API
Eyes
Closed

MLI
Eyes
Open

MLI
Eyes
Closed

Time
(sec)

Overall
Directional
Control
Score (%)

Step Length Variability
Comfortable Walking

-0.946

0.576

0.494

0.738

0.429

.331

.417

0.914

-0.789

Fast Walking

-0.946

0.511

0.516

0.703

0.459

.273

.426

0.833

-0.845

Comfortable Walking

-0.850

0.373

0.619

0.584

0.616

.121

.461

0.942

-0.787

Fast Walking

-0.826

0.246

0.712

0.503

0.719

.006

.524

0.844

-0.857

Swing phase

.371

-.071

-.672

.103

-.437

-.163

-.781

-.222

.120

Stance phase

-.371

.071

.667

-.107

.432

.165

.778

.218

-.114

Double Limb Support

-.371

.097

.679

-.082

.434

.188

.796

.217

-.123

Stride Length Variability

% of Gait Cycle in:

Correlation coefficients (Spearman’s ρ for Berg Balance Scale scores and Pearson's r for postural stability and limits of
stability measures) denote the relationships between gait parameters during comfortable and fast walking and balance
measures. Significant (p<0.05) correlations are bolded.
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cadence decreased by 17% and 21% during comfortable and fast walking, respectively,
from baseline to 24 months.
A linear mixed effect (LME) model was applied to determine whether gait
parameters exhibited a significant linear change from baseline to 24 months in subjects
with FA. Using this LME model, mean gait velocity during comfortable walking
demonstrated a significant 0.008 m/s average unit decrease per month over 24 months
(β=-0.008, SE=0.002, p=0.002). Mean gait velocity during fast walking demonstrated a
significant 0.01 m/s average unit decrease per month (β=-0.013, SE=0.003, p=0.003).
Similarly, mean cadence exhibited a significant average unit decrease per month during
both comfortable and fast walking (0.61 steps/min, β=-0.610, SE=0.227, p=0.031 and
0.77 steps/min β=0.766, SE=0.272, p=0.026, respectively) over 24 months.

Step and Stride Length
Mean step and stride lengths over 12 months for controls and over 24 months for
FA subjects are shown in Figure 5. There were no significant changes in these
parameters from baseline to 12 months for controls (p>0.05). Step and stride length
decreased by 14% and 18% for comfortable and fast walking, respectively, in subjects
with FA over 24 months.
Using LME modeling, step and stride length exhibited significant linear changes
over 24 months. Mean step length during comfortable walking exhibited a significant
0.32 cm average unit decrease per month over 24 months (β=-0.315, SE=0.091,
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Figure 4. Gait Velocity and Cadence
*Asterisks indicate significant linear change (p<0.05) over 24 months as determined
using LME model.
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p=0.010), while mean step length during fast walking showed a significant 0.48 cm
average unit decrease per month (β=-0.4761, SE=0.140, p=0.012). Mean stride length
for comfortable walking demonstrated a significant 0.64 cm average unit decrease per
month (β=-0.636, SE=0.184, p=0.011), while mean stride length during fast walking
revealed a significant 0.96 cm average unit decrease per month (β=-0.955, SE=0.288,
p=0.013).

Step and Stride Length Variability
The mean step and stride length variability over 12 months for controls and over
24 months for FA subjects are shown in Figure 6. There were no significant changes in
these parameters from baseline to 12 months in controls (p>0.05). Step length
variability increased by 20% and 29%, and stride length variability increased by 16%
and 24% for comfortable and fast walking, respectively, in subjects with FA from
baseline to 24 months.
Using LME modeling, step length variability demonstrated a significant linear
change over time. Step length variability during fast walking demonstrated a 0.10 (cm)
average unit increase per month from baseline to 24 months (β=0.098, SE=0.029,
p=0.012). However, no significant linear change was found for step length variability
during comfortable walking or for stride length variability during either comfortable or
fast walking (p>0.05).
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Figure 5. Step and Stride Length
*Asterisks indicate significant linear change (p<0.05) over 24 months as determined
using LME model.
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Figure 6. Step and Stride Length Variability
*Asterisks indicate a significant linear change (p<0.05) over 24 months as determined
using LME model
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Percent of Gait Cycle in Swing, Stance and Double Limb Support
Mean percent of the gait cycle spent in swing, stance and double limb support
from baseline to 12 months for controls and from baseline to 24 months for FA subjects
are shown in Figure 7. There were no significant changes in these parameters from
baseline to 12 months in controls (p>0.05). For subjects with FA, percent of the gait
cycle spent in swing phase decreased 10% and 14% for comfortable and fast walking,
respectively, while percent of the gait cycle spent in stance phase increased 5% and 8%
for comfortable and fast walking, respectively. Percent of the gait cycle spent in double
limb support increased by 19% and 32% for comfortable and fast walking, respectively.
Using LME modeling, certain gait variables exhibited a significant, non-linear
quadratic relationship indicating that the rate of change (slope of the line) was
dependent on the time elapsed. All variables as a percentage of the gait cycle during
comfortable walking exhibited a significant non-linear quadratic relationship. There was
a significant non-linear, quadratic relationship for swing percent of the gait cycle during
comfortable walking (β=-0.012, SE=0.005, p=0.037). Similarly, there was a significant
non-linear, quadratic relationship for stance (β=0.012, SE=0.005, p=0.036) and double
limb support (β=0.026, SE=0.011, p=0.038) percent of the gait cycle during comfortable
walking, indicating that the rate of change increased with time from baseline to 24
months. There were no significant changes in percent of the GC spent in swing, stance
or double limb support during fast walking from baseline to 24 months (p>0.05).
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Figure 7. Percent of Gait Cycle in Swing, Stance and Double Limb Support
*Asterisks indicate significant non-linear quadratic change (p<0.05) over 24 months
using LME model.
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Longitudinal Changes in Balance
Berg Balance Scale
Berg Balance Scale scores for individual FA subjects are shown in Figure 8a,
while mean scores for FA and control groups are shown in Figure 8b. One subject with
FA had lower BBS scores than the other FA subjects at all testing sessions. She also
had the longest disease duration (16 years) compared to the other subjects.
Additionally, the two subjects with LOFA (F6 and F7) and the subjects with incomplete
genetic information (F8) displayed higher BBS scores than the other FA subjects at all
testing sessions. Subjects with FA exhibited a decline in mean BBS scores of 7% at 12
months, and 18% by 24 months at which time the mean BBS score was 36 with a range
from 11 to 49. By 24 months, 5 of 7 subjects with FA fell below the BBS cut-off score of
40, which is indicative of very high fall risk. Berg Balance Scale scores for the control
group did not change from baseline to 12 months (p>0.05).
The LME model was applied to determine whether BBS scores demonstrated a
significant linear change from baseline to 24 months in subjects with FA. BBS scores
demonstrated a significant linear change over time. The mean BBS scores exhibited a
significant 0.27 average unit decrease per month over 24 months (β=-0.266, SE=0.053,
p=0.001) as displayed in Figure 8b.

Postural Stability
Mean postural stability parameters (OSI, API and MLI) over 12 months for
controls and over 24 months for FA subjects are shown in Figure 9. In the control group,
there were no significant changes in postural stability parameters from baseline to
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Figure 8. Berg Balance Scale
* Asterisks indicate a significant linear change (p<0.05) over 24 months as determined
using LME model.
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12 months as determined using paired t-tests (p>0.05). Postural stability parameters
increased from baseline to 24 months during testing with both eyes open (EO) and eyes
closed (EC) in FA subjects, denoting worsening postural control. OSI increased 24%
and 33% with EO and EC, while API increased 25% and 40% and MLI increased 22%
and 24% with EO and EC, respectively.
The LME model was applied to determine whether postural stability parameters
(OSI, API, and MLI) demonstrated a significant linear change from baseline to 24
months. The OSI and API with EO and EC demonstrated a significant linear change
from baseline to 24 months. Mean OSI with EO demonstrated a significant 0.028
average unit increase per month from baseline to 24 months (β=0.028, SE=0.009,
p=0.013). Additionally, there was a significant effect of time for OSI with EO (β=0.002,
SE=0.001, p=0.037) indicating that the rate of change increased as months elapsed
from baseline to 24 months. Mean OSI with EC revealed a significant 0.089 average
unit increase per month over 24 months (β=0.089, SE=0.028, p=0.016). Mean API with
EO demonstrated a significant 0.022 average unit increase per month over time
(β=0.022, SE=0.008, p=0.025). Mean API with EC revealed a significant 0.023 average
unit increase per month over 24 months (β=0.023, SE=0.647, p=0.011). Similar to OSI
with EO, there was a significant effect of time for API with EC (β=-0.006, SE=0.002,
p=0.018). The MLI with EO demonstrated a significant non-linear, quadratic relationship
using the LME model (Figure 9c). The average unit increase per month for MLI with EO
was not significant (β=0.015, SE=0.008, p=0.112). However, a significant non-linear,
quadratic relationship was found for MLI with EO (β=0.002, SE=0.000, p=0.042)
indicating that the rate of change increased over time.

66

A

B

C

Figure 9. Postural Stability
* Asterisks indicate a significant linear (or non-linear) change (p<0.05) in FA group over
24 months as determined using LME model
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Limits of Stability
Limits of stability parameters reflect dynamic standing balance. Mean LOS
parameters over 12 months for controls and over 24 months for FA subjects are shown
in Figure 10. In the control group, with the exception of the forward directional control
score (p<0.05), no other significant changes in LOS scores were apparent. The forward
directional control score (depicted in Figure 10c) increased from baseline to 12 months
in controls as determined using paired t-tests (t=-3.706, p=0.008), indicating an
improvement in dynamic balance. One FA subject was unable to complete the LOS test,
therefore, results are based on 7 subjects with FA and their 7 matched controls.
Individuals with FA took longer to complete the LOS task and had an overall directional
control score nearly half that of controls. In subjects with FA, time to complete the LOS
test increased by 2%, while the overall directional control score decreased by 9% from
baseline to 24 months.
Linear mixed effect modeling was applied to determine whether limits of stability
(LOS) parameters exhibited a significant linear change from baseline to 24 months in
subjects with FA. The model revealed no significant changes in either time to complete
the LOS test (Figure 10a) or in the overall directional control scores (Figure 10b) from
baseline to 24 months. LME modeling did reveal a significant linear change in the
backward directional control scores over 24 months as depicted in Figure 10d. The
mean backward directional control score exhibited a significant 0.71 average unit
decrease per month from baseline to 24 months in subjects with FA (β=-0.713, SE=
0.238, p=0.024).
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Figure 10. continued on next page
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*

Figure 10. Limits of Stability
*Asterisk indicates significant change in control group over 12 months using paired ttest. **Asterisk indicates significant linear change in FA group over 24 months as
determined using LME model (p<0.05).
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Correlations
Temporal Demographic Variable and Gait and Balance Correlations
Pearson’s product correlation coefficient (r) was employed to assess the
relationship between temporal demographic and gait and balance variables at 24
months in subjects with FA. Subject age was not correlated with any variable at 24
months (p>0.05). Disease duration was positively correlated with step length variability
during fast walking (r=.761, p=0.047), MLI with EO (r=.797, p=0.032) and with the
backward/right directional control scores (r=.891, p=0.017). A relationship was identified
between years since FA diagnosis and OSI with EO (r=0.796, p=0.032). Temporal
demographic variables were not correlated with any other balance or gait variables
(p>0.05).

Clinical Rating Scale Scores and Gait and Balance Correlations
Correlations among clinical rating scale scores and gait and balance parameters
are summarized in Table 6. Spearman’s rank correlation coefficient (ρ) was used to
investigate the relationship between BBS and FARS scores and balance and gait
parameters for subjects with FA at 24 months. There was a significant negative
correlation between BBS scores and MLI with EC (p=0.014). A significant positive
correlation was revealed between BBS scores and the LOS forward directional control
score (p=0.042). The BBS scores were positively associated with gait velocity during
both comfortable and fast walking (p=0.036) and with cadence during fast walking
(p=0.023). Berg Balance Scale scores were not related to any other balance or gait
parameters (p>0.05). FARS total scores showed a positive correlation to API with EO
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(p=0.003) and a negative correlation to the right, left and forward left directional control
scores (p<0.01, p=0.005 and p=0.042, respectively). There was a significant, positive
correlation between FARS total scores and step and stride length variability during fast
walking (p=.007 and p=.014, respectively). FARS total scores were not related to any
other balance or gait parameters (p>0.05). FARS Upright Stability scores were not
related to any balance or gait variables (p>0.05).

Quantitative Gait and Balance Correlations
Correlations among balance and gait parameters are summarized in Table 6.
Pearson’s product correlation coefficient (r) was employed to assess the relationship
between quantitative balance and gait parameters at 24 months in subjects with FA.
There were several significant correlations identified between these parameters,
particularly, between postural stability parameters and step and stride length variability.
The OSI with EC was positively correlated with stride length variability during
comfortable walking (p=0.006) and with step and stride length variability during fast
walking (p=0.014 and p=0.004, respectively). A relationship was revealed between API
with EO and step length variability during comfortable walking (p=0.025). In addition,
there was a positive correlation between API with EC and stride length variability during
comfortable walking (p=0.008) and step and stride length variability during fast walking
(p=0.047 and p=0.024, respectively). MLI with EC was negatively correlated with gait
velocity during comfortable walking (p=0.018).
The LOS overall directional control scores were negatively associated with step
length variability during fast walking (p=0.038) only. The right directional control scores
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were negatively correlated with step and stride length variability during fast walking
(p=0.006 and p=0.018, respectively); as were the left directional control scores (p=0.008
and p=0.039, respectively). The forward/right directional control scores were negatively
correlated with step and stride length variability during comfortable walking (p=0.008
and p=0.007, respectively); as were the forward/left directional control scores (p=0.008
and p=0.006, respectively) and the backward/left directional control scores (p=0.023).
No other balance parameters were significantly correlated with gait parameters at 24
months (p>0.05).
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Table 6. Correlations among Clinical Rating Scale Scores and Gait and Balance Parameters at 24 Months
Postural Stability

Limits of Stability

BBS
(ρ)

FARS
(ρ)

OSI
EC

API
EO

API
EC

MLI
EC

Overall Fwd Bwd
DCS
DCS DCS

Right
DCS

Left
DCS

Fwd
Right
DCS

Fwd
Left
DCS

Bwd
Left
DCS

BBS(ρ)

1.000

-.679

-.321

-.714

-.214

-.857*

.429

.829*

.771

.486

.257

.600

.657

.600

FARS(ρ)

-.679

1.000

.643

.929*

.429

.750

-.771

-.714

-.200

-1.0*

-.943*

-.771

-.829*

-.771

Comfortable Gait (r)
Velocity

.786*

-.286

-.264

-.403

.123

-.840*

.043

.205

.231

.163

-.201

.375

.156

.491

Step SD

-.464

.714

.792

.815*

.645

.601

-.682

-.649

-.083

-.741

-.678

-.925*

-.924*

-.874*

Stride SD

-.357

.679

.896*

.565

.886*

.399

-.700

-.658

-.120

-.761

-.703

-.932*

-.935*

-.873*

Velocity

.786*

-.286

-.245

-.355

.118

-.773

.240

.413

.301

.303

-.034

.376

.161

.583

Cadence

.821*

-.429

-.146

-.387

.262

-.800

.209

.363

.539

.307

-.061

.166

-.070

.420

Step SD

.429

.893*

.855*

.686

.761*

.504

-.836*

-.712

-.315

-.938*

-.928*

-.701

-.737

-.719

Stride SD

-.464

.857*

.912*

.611

.821*

.531

-.727

-.599

-.295

-.889*

-.833*

-.674

-.690

-.671

Swing%

.821

-.357

-.225

.038

.076

-.643

.181

.330

.582

.279

-.084

.089

-.146

.350

Stance%

-.821

.357

.225

-.038

-.076

.643

-.183

-.331

-.580

-.280

.082

-.089

.146

-.352

Double%

-.821

.357

.224

-.026

-.081

.651

-.186

-.335

-.574

-.282

.080

-.094

.141

-.358

Fast Gait (r)

Correlation coefficients (Pearson’s (r); Spearman’s (ρ) for BBS and FARS) denoting relationships among clinical rating scale
scores and gait and balance parameters. * signifies p<0.05 and significant correlations are bolded. LOS Directional control
score (DCS), Forward (Fwd), Backward (Bwd), Step length variability (Step SD), Stride length variability (Stride SD), Swing
percent of gait cycle (Swing %), Stance percent of gait cycle (Stance %), Double limb support percent of gait cycle (Double %)
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CHAPTER FOUR
DISCUSSION AND CONCLUSIONS

The purpose of this study was to characterize the gait and balance disorder in
adults with FA and to investigate changes over time in quantitative gait and balance
parameters and the Berg Balance Scale. Additionally, this study investigated the
relationship among temporal demographic variables, clinical rating scale scores and gait
and balance parameters. This is the first longitudinal study to investigate changes in
both gait and balance parameters and clinical rating scales in adults with FA.

Gait
At baseline, adults with FA exhibited all of the classic signs of gait ataxia (Ilg et
al., 2007; Morton et al., 2003; Morton et al., 2004, 2007; Palliyath et al., 1998; Stolze et
al., 2002). Although researchers have studied the gait disorder of individuals with FA
(Croarkin et al., 2009; Milne et al., 2014; Serrao et al., 2012), there is very limited
information on balance deficits in FA (Diener et al., 1984; H. Diener et al., 1984; Ilg et
al., 2009) and no studies have investigated the relationship between balance deficits
and the gait disorder in this patient population.
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Gait Speed
The control subjects in this study had an average gait velocity of 1.4 m/s during
comfortable walking, representative of norms for adults in their age group (i.e. 1.3-1.5
m/s) (Bohannon, 1997; Bohannon et al., 2011). Mean gait velocity in adults with FA (0.7
m/s) was not only significantly slower than controls, but 6 of 8 subjects with FA walked
below speeds required for community ambulation, considered faster than 0.8 m/s (Fritz
et al., 2009). These results are consistent with studies reported for individuals with a
variety of cerebellar ataxias (Morton et al., 2003; Morton et al., 2010; Palliyath et al.,
1998) and with reports of reduced gait velocity in people with FA across age ranges
(Croarkin et al., 2009; Gouelle et al., 2013; Milne et al., 2014) The present longitudinal
study extends the results of previous cross-sectional studies and demonstrated a
significant decline in gait velocity and cadence during both comfortable and fast walking
over 24 months in adults with FA. By 24 months, FA subjects had an average gait
velocity of 0.51 m/s for comfortable walking and 0.69 m/s for fast walking; both falling
below the speed considered necessary for community ambulation. Self-selected walking
speed is considered a valid, reliable, sensitive and specific measure, which correlates
with functional abilities, balance confidence, and falls risk (Fritz et al., 2009; Studenski
et al., 2011). In addition, gait velocity is considered a global indicator of walking
impairment with potential to predict future health status and functional decline, the need
for adaptive or assistive devices, and whether the individual is capable of household or
community ambulation (Fritz et al., 2009). Significantly decreased gait velocity in adults
with FA may be predictive of future functional decline in walking and the need for gait
assistive devices or a wheelchair for community mobility.
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Step and Stride Length
In the present study, adults with FA had significantly shorter step and stride
lengths than their healthy peers and exhibited a significant decline in these parameters
over 24 months. Decreased step and stride length have been observed in people with
ataxic gait and these impairments are thought to contribute to decreased gait velocity
(Ilg et al., 2007; Morton et al., 2003; 2010; Palliyath et al., 1998). Palliyath et al. (1998)
and Ilg et al. (2007) reported that people with cerebellar degeneration showed
significantly reduced step and stride lengths compared to healthy individuals, which the
authors proposed contributed to slower gait velocities. Other researchers reported that
subjects with FA exhibited shorter step lengths than subjects with SCA and both groups
walked slower than healthy controls (Serrao et al., 2012); these authors also found a
strong correlation between step length and gait velocity. Croarkin and colleagues (2009)
reported that adolescents with FA demonstrated a slower gait velocity, shorter stride
lengths and took fewer steps per minute compared to healthy adolescents and children
with less advanced disease. Reduced gait velocity was reported in a study of subjects
with FA, whose ages ranged from 12 to 25 years (Gouelle et al., 2013). These authors
proposed that the subjects with FA reduced their gait velocity as a compensatory
mechanism to increase stability while walking. However, they did not specifically test
balance. Adults with FA have balance and gait impairments that may predispose them
to falls. They may utilize compensatory strategies to limit their step lengths and reduce
the speed of their walking to avoid loss of balance, falls and subsequent injury.
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Gait Variability
Gait variability is well documented in people with cerebellar ataxia and is related
to functional walking impairment (Ilg et al., 2007; Morton et al., 2003; Palliyath et al.,
1998), gait speed (Schniepp et al., 2012; Wuehr et al., 2013) and falls (Schniepp et al.,
2014; Van de Warrenburg et al., 2005). Although increased gait variability is seen in
many movement disorders, it is considered a characteristic feature of ataxic gait
(Hausdorff, 2005; Ilg et al., 2013). Subjects with a variety of cerebellar ataxias exhibited
significant variability in step and stride length, cadence, as well as step and stance time
(Palliyath et al., 1998). Serrao and colleagues (2012) emphasized the significant interand intra-subject variability of all spatiotemporal gait parameters in subjects with both
FA and SCA, and proposed that it was difficult to describe a clear ataxic gait pattern due
to the high level of variability. A recent study by Gouelle et al. (2013) evaluated gait
variability in people with FA using a Gait Variability Index (GVI), which combines nine
gait parameters to assess variability. The authors reported that gait variability was
significantly higher in the FA group compared to healthy subjects and that the GVI was
a useful method for studying variability in this population. The present study
corroborates results of these studies by identifying significant step and stride length
variability in adults with FA compared to healthy controls. Additionally, there was a
significant increase in step length variability for fast walking from baseline to 24 months.
Step and stride length variability were also greater during fast walking as compared to
comfortable, self-selected walking. One study demonstrated that temporal gait variability
was increased in patients with cerebellar and vestibular dysfunction and the amount of
variability was related to the speed of walking (Schniepp et al., 2012). In the patients
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with cerebellar dysfunction, variability increased during both slow and fast walking, but
not during walking at comfortable, self-selected speeds. Another study demonstrated
that both temporal and spatial variability were impaired in subjects with cerebellar ataxia
and this depended on walking speed (Wuehr et al., 2013). These authors reported that
increased stride time and stride length variability occurred at slow and maximal walking
speeds. Additionally, they described reduced variability when healthy subjects walked at
maximal walking speeds, in contrast to subjects with cerebellar ataxia. The authors
proposed that the gait cycle may become more consistent with increasing walking
speeds in healthy individuals, yet the increased variability at faster speeds in people
with ataxia may reflect impaired cerebellar control of locomotor function (Wuehr et al.,
2013). Findings of increased gait variability during fast walking in adults with FA concur
with these studies.
Gait variability is considered a predictor of falls in the elderly and in people with
neuromuscular disorders (Balasubramanian et al., 2009; Day et al., 2012; Grimbergen
et al., 2008; Socie et al., 2013). Falls are also common in people with ataxia, including
FA, and this is thought to relate to increased gait variability. Hausdorff (2005) stated that
gait variability might be a stronger indicator of falls risk than average speed of walking,
stride length or stride time in neurologic populations including ataxia. He proposed that
gait variability may more strongly reflect the central nervous system’s ability to regulate
gait and maintain a steady walking pattern. Schniepp et al (2014) reported a significant
relationship between gait variability and falls risk, particularly during slow walking, in
people with a variety of cerebellar ataxias. In addition, increased gait variability in an
anterior-posterior direction (compared to a medial-lateral direction) was associated with
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a higher risk of falls in the subjects. In the present study, step length variability
increased significantly over 24 months for fast walking, but not for comfortable, selfselected walking in adults with FA. These subjects may have slowed their gait speed to
avoid the instability and increased variability which occurred during fast walking as a
compensatory mechanism to avoid loss of balance. This is confirmed by findings of a
significant correlation between step length variability during fast walking and balance as
assessed by both objective balance measures and the Berg Balance Scale. Thus,
increased gait variability could be considered indicative of balance impairment in adults
with FA and worsening balance could lead to greater gait variability, particularly at
increased speeds.

Percent of Gait Cycle in Swing, Stance and Double Limb Support
Over 24 months, adults with FA spent less percent of the gait cycle in swing
phase and a greater percent of the gait cycle in stance phase and double limb support
during comfortable walking. In a one year longitudinal study, Morton and colleagues
(2010) reported that subjects with mixed cerebellar ataxias spent increased time in
double limb support at 6 and 12 month follow-up compared with baseline, but these
authors found no significant change in percent of time spent in stance phase. Children
without disability and normal adults tend to spend 40-44% of the gait cycle in swing
phase and 56-60% of the gait cycle in stance phase. Within these age groups, the time
spent in swing and stance phase typically does not change with age (Perry, 1992). A
study of children and adolescents with FA demonstrated that percent of time spent in
stance phase and double limb support was significantly longer than in normal
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adolescents (Croarkin et al., 2009). Specifically, adolescents with FA, who were
independent walkers, spent less time in swing phase (35%), and more time in stance
phase (65%) and double limb support (30%) than healthy adolescents. These results
correspond with findings in adults with FA, however, adults spent even less time in
swing phase (31%) and more time in stance phase (69%) and double limb support
(39%). The adults with FA in the present study may have more advanced disease and
greater gait disability than adolescents with FA. This may also be a reflection of
worsening dynamic balance in both populations (adults and adolescents). These
individuals may spend more time with both feet in contact with the ground to avoid the
inherent instability during swing phase, when they have to balance on one foot. Serrao
and colleagues (2012), who described the ataxic gait pattern as wide based walking
with increased double limb support duration, confirmed this gait dysfunction. The
authors proposed this gait pattern was a strategy used to compensate for the wide
oscillations of the center of mass and poor dynamic balance during walking in people
with ataxia. Alternatively, they also indicated that increased stance duration and
decreased swing duration and step length could be used to avoid loss of balance and
falls because single limb support is the most unstable phase of gait (Serrao et al.,
2012).

Balance
Balance is critical to performing daily functional activities in both sitting and
standing positions. Dynamic standing balance is particularly important as a person
walks. Adults with FA demonstrated significantly higher postural stability indices,
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decreased limits of stability scores and lower BBS scores than their healthy, peers
indicative of balance impairment. This is the first natural history study to examine
changes over time in balance in adults with FA using both objective measures and a
balance specific clinical rating scale, the BBS. Additionally, this study investigated the
relationship between balance parameters, the BBS and gait parameters.

Berg Balance Scale
The FA subjects in this study had lower mean BBS scores compared to their
healthy peers. All controls subjects attained the maximum BBS score at baseline and
this did not change at 12 months. Subjects with FA demonstrated a significant decline in
BBS scores at 24 months. The BBS proved to be an appropriate balance specific
clinical rating scale for use in FA, and all subjects were able to perform all test items
within 15-20 minutes. The BBS has been shown to be a valid and reliable balance
assessment for community dwelling elderly and people with other neurological disorders
(Datta et al., 2012; Muir et al., 2008) Additionally, the BBS has been shown to be
correlated with measures of postural sway using dynamic posturography (Berg et al.,
1992). Attainment of a BBS score less than 45 indicates increased falls risk (Berg et al.,
1992), while scores less than 40 are associated with a near 100% risk for falls
(Shumway-Cook et al., 1997). Two of 8 FA subjects in the present study demonstrated
BBS scores below the cut-off for falls risk at baseline, while 5 of 7 FA subjects fell below
the lower cut-off score of 40 by 24 months. This indicates that the majority of FA
subjects in this study were at high risk to fall by the end of the study. Four subjects with
FA, who had been ambulatory at baseline, had begun using a wheelchair as their
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primary means of community mobility by the end of the study. Although balance
impairment is not a cause of all types of falls and is not present in all people who fall, it
has been shown to increase a person’s risk for falling (Muir et al., 2008).
The BBS has been used in other longitudinal studies to investigate change in
balance over time in the community dwelling elderly (Muir et al., 2008), in people with
spinal cord injury (Datta et al., 2012), and in those with stroke (English et al., 2006; Mao
et al., 2002). Muir and colleagues (2008) found the BBS had good discriminate ability to
predict multiple falls in elderly individuals, who were tested monthly for one year.
Another study reported the BBS captured a significant amount of variation in balance
recovery in subjects with incomplete spinal cord injury and correlated well with the 10
meter walk test, 6 minute walk test, and SCI Functional Ambulation Index (Datta et al.,
2012). The BBS was able to discriminate between those with SCI who were slower to
recover balance over time from those with faster balance recovery. Recently, a Delphi
survey was conducted on balance assessments used with individuals with a variety of
cerebellar ataxias (Winser et al., 2014). These authors suggested that balance
assessment in people with ataxia is challenging secondary to a lack of standardized
assessments. The BBS, the Scale for the Assessment of Ataxia (SARA) and the Timed
Up and Go were identified as the best outcome measures to use with the ataxia
population; with 75% consensus among the experts surveyed (Winser et al., 2014). The
BBS was determined to have excellent inter-rater reliability, low measurement error and
was able to discriminate between ataxic fallers and non-fallers. Ilg and colleagues
(2009) used the BBS, SARA, ICARS and motion analysis to assess balance, gait and
disease severity in subjects with a variety of degenerative ataxias before and after a 4
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week intensive coordination training program. They reported significant improvements in
BBS, SARA and ICARS scores for all groups following intervention, but the cerebellar
ataxia group showed retention of improvements 8 weeks after treatment, whereas those
with sensory ataxias did not (Ilg et al., 2009). In the present study, the BBS was found
to be useful and appropriate as a balance specific assessment for adults with FA. In
addition, this test demonstrated sensitivity to change over time. The BBS would have to
be tested in a much larger cohort of subjects with FA to assess its psychometric
properties.

Postural Stability and Limits of Stability
Postural stability and LOS were tested on the Biodex Balance System SD.
During the postural stability test, the greater the movement of an individual’s center of
pressure around a center point on the balance platform, the higher the postural stability
index generated by the system (Arnold et al., 1998; Sherafat et al., 2013). Adults with
FA demonstrated significantly higher postural stability indices during quiet standing on
the balance platform with eyes open and eyes closed compared to healthy individuals.
Of particular note was the significantly higher postural stability indices with eyes closed,
compared to healthy individuals. The overall stability index and the anterior posterior
index were nearly 50% greater with eyes closed compared with eyes open in subjects
with FA. Whereas, there was little difference in postural stability indices in controls with
eyes open or closed. These findings would suggest subjects with FA have developed an
over-reliance on vision to maintain balance, possibly to compensate for diminished
somatosensation and proprioception in the lower extremities. It is well documented that
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people with FA have somatosensory loss in the lower extremities due to involvement of
the peripheral nerves, dorsal root ganglia, and spinal cord dorsal columns (Della Nave
et al., 2008; Marmolino, 2011). Other populations with lower extremity sensory and
proprioceptive loss demonstrate increased postural sway in static standing and
decreased dynamic balance, which worsens with eyes closed (Cameron et al., 2010;
Emam et al., 2009; Mauritz et al., 1979; Nardone et al., 2006; Sullivan et al., 2010).
Normally, individuals use a combination of three sensory systems to maintain balance:
vision, somatosensory and vestibular. People with impairment in one of these systems
may utilize the other two systems to compensate for this loss. This may explain why
adults with FA in the present study had significantly higher postural stability indices
during quiet standing with eyes closed. In this situation, two systems required to
maintain static balance, sensory and visual, were compromised.
Dynamic standing balance deficits were also exhibited by adults with FA when
performing the LOS task on the balance platform. This test required the subject to shift
their weight in different directions to move a cursor from a center target to peripheral
targets. Individuals with FA took longer to complete the LOS task and had an overall
directional control score nearly half that of controls, indicative of impaired dynamic
balance. Also, control subjects exhibited a relatively direct path of movement when
performing the LOS task, whereas, FA subjects displayed undershooting and
overshooting of the targets. Difficulty controlling movement of the COM during a
dynamic balance task, as was observed in FA subjects during the LOS task, may be
indicative of problems controlling COM movements during walking. Walking requires
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ongoing adjustments of the COM over the base of support as the person shifts weight
from one leg to the other, transitioning from stance phase to swing phase on each leg.
Only three studies of postural sway in subjects with ataxia have included
individuals with FA (Diener et al., 1984; 1984; Ilg et al., 2009). In one study, 8 subjects
with FA exhibited an omnidirectional, low frequency postural sway with a stronger
medial-lateral sway component during quiet standing, which worsened significantly with
eyes closed (Diener et al., 1984). The present findings do not fully agree with this study.
Although adults with FA showed significantly greater postural stability indices in both
anterior-posterior and medial-lateral directions compared to controls, the anteriorposterior index was greater and increased over time in subjects with FA. Another study
by Diener and colleagues (1984) reported that subjects with FA had an increased
latency in EMG response of the anterior tibialis muscle and a backward loss of balance
during a postural perturbation on a moving platform. The anterior tibialis muscles should
have responded quickly to prevent the loss of balance backwards as the platform
moved forward. Subjects with FA in the present study showed worsening anteriorposterior postural stability indices and backward directional control scores over 24
months, indicating that they may tend to lose balance forwards or backwards. However,
they were standing on a non-moving balance platform so did not have to react to a
perturbation. A third study investigated body sway of individuals with a variety of ataxias
before and after rehabilitation interventions (Ilg et al., 2009), and reported that subjects
with pure cerebellar degeneration showed improved postural sway following training,
while those with sensory ataxia did not. The study included three subjects with FA,
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however, their data was not analyzed separately from that of subjects with other types
of sensory ataxia.
Most balance research in ataxia has focused on individuals with SCA, who
exhibit increased standing postural sway during quiet standing (Bakker et al., 2006;
Mohan et al., 2009; Van de Warrenburg et al., 2005). Mohan and colleagues (2009)
used the Biodex Balance System and reported higher postural stability indices (OSI,
API & MLI) in subjects with SCA compared with healthy controls. The mean value of
API was also significantly higher than MLI in subjects with SCA. Fourteen of twenty
SCA subjects could not complete the LOS task on the Biodex, but those who did took
significantly longer and had significantly lower directional control scores than controls
(Mohan et al., 2009). The findings of the present study parallel those of Mohan et al.
(2009); the mean value of the anterior-posterior index was greater than the mean
medial-lateral index in subjects with FA. Additionally, a significant decline in the overall
stability index, anterior-posterior index and backward directional control scores over 24
months were noted in adults with FA. Van de Warrenburg and colleagues (2005) used
angular velocity transducers mounted on the backs of 11 subjects with SCA and 11
healthy controls to quantitatively measure trunk angle displacement and angular velocity
in a pitch (AP) and roll (ML) plane as subjects performed a series of standing and gait
tests. They determined that trunk angle displacement and angular velocity were
significantly larger in SCA patients than in controls. Additionally, they noted trunk sway
abnormalities were greater in the pitch (anterior-posterior) direction than in the roll
(medial-lateral) direction. Standing on foam, particularly with eyes closed, led to a
further increase in anterior-posterior trunk sway in this patient cohort. The authors
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proposed the increased sway during standing on foam, particularly with eyes closed,
was due to an absence of visual feedback and a distortion of proprioceptive input from
the lower extremities (Van de Warrenburg et al., 2005). The response of these subjects
with SCA was similar to that seen in adults with FA who demonstrated increased
postural stability indices with eyes closed compared to eyes open during quiet standing.
People with FA have neurologic involvement beyond the cerebellum and its
pathways so they present differently from individuals with strictly cerebellar
degeneration. Additionally, in FA, there is involvement of the peripheral nerves, cell loss
in the dorsal root ganglia, and degeneration of the dorsal columns of the spinal cord.
MRI studies have shown significant shrinkage in the cervical spinal cord in people with
FA (Chevis et al., 2013). Only later in the disease process do brainstem nuclei and the
cerebellum become involved. There are certain limitations when comparing FA balance
and gait deficits to individuals with strictly cerebellar degeneration. FA does show some
similarities to the neurologic sequelae of chronic alcoholism, where a combination of
peripheral neuropathy and cerebellar involvement is seen. Using posturography,
anterior-posterior postural sway was shown to be more pronounced than medial-lateral
sway in subjects with chronic alcoholism and cerebellar anterior lobe atrophy (Mauritz et
al., 1979). These subjects exhibited increased anterior-posterior postural sway with
eyes closed, but were able to stabilize their body with eyes open. The authors
conducted follow-up testing with the same subjects over five years and noted further
increases in anterior-posterior postural sway as the subject’s disease progressed
(Dichgans et al., 1983). The present study demonstrated similar findings over two years,
i.e., significant increases in anterior-posterior postural stability indices, which was worse
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with eyes closed. People with chronic alcoholism experience peripheral neuropathy and
cerebellar vermian loss, which is thought to contribute to balance loss and gait ataxia
even after months of sobriety (Fein et al., 2012; Smith et al., 2011; Sullivan et al., 2006,
2010). These individuals exhibit abnormally long sway paths, preferential sway direction
in an anterior-posterior plane and less postural sway with the use of stabilizing factors.
Despite significant increased postural sway in alcoholics, these individuals were able to
use visual and tactile cues to significantly reduce their postural sway (Sullivan et al.,
2010). In another study, Smith and Fein (2011) reported that gait and balance of male
and female alcoholics can continue to recover following long term abstinence from
alcohol. However, balance deficits persist especially during standing balance activities
with eyes closed. People with FA showed lower postural stability indices with eyes open
compared to eyes closed, yet were not able to use sensory cues to attain indices that
approached their matched, healthy peers even with eyes open. In summary, the
direction of impaired postural sway (AP) observed in people with SCA and chronic
alcoholism was consistent with the greater anterior-posterior postural stability indices
attained by adults with FA.
The present study is the first to investigate both static and dynamic balance in
adults with FA and identify correlations between balance and gait parameters. Morton
and Bastian (2003) reported subjects with cerebellar damage and balance deficits
demonstrate most of the classic features of gait ataxia, whereas subjects with primarily
leg placement deficits did not. Leg placement deficits are indicative of lower extremity
incoordination. The subjects with balance deficits were significantly impaired on 5 of 10
measures of walking, whereas those with leg placement deficits were impaired on only
89

one measure of walking. Certain gait parameters, including stride length variability, were
abnormal in the balance deficit subgroup, but not impaired in the leg placement deficit
subgroup. These authors concluded that balance deficits are a stronger indicator of
cerebellar ataxia during level ground walking than lower extremity coordination deficits
(Morton et al., 2003). Other authors suggest the high level of gait variability seen in
people with ataxia may represent a combination of balance impairment, lower extremity
incoordination, and inaccurate strategies to prevent loss of balance while walking (Ilg et
al., 2013). The present study demonstrated adults with FA have both static and dynamic
balance deficits and there is a relationship between balance variables and gait
parameters, which is consistent with findings of previous research.

Longitudinal Research
The present study demonstrated statistically significant changes in both balance
and gait parameters and the Berg Balance Scale in adults with FA over two years.
There has only been one other longitudinal, natural history study of quantitative gait and
balance parameters and clinical rating scales in individuals with cerebellar ataxia, but
this study did not include subjects with FA (Morton et al., 2010). These investigators
utilized instrumented gait and balance measures and the ICARS to study the natural
history of change over one year in 16-69 years olds with a variety of cerebellar
disorders. They divided subjects into three groups; those with degenerative cerebellar
disease (degenerative group), subjects with “static” unchanging cerebellar lesions
following stroke or tumor (static group), and healthy controls. Significant differences in
gait and balance measures and ICARS scores were observed between cerebellar
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subjects and healthy controls. There was significant worsening of ICARS total scores
and ICARS posture and gait sub-scores over the three testing sessions (baseline, 6
months and 12 months) in the degenerative group, but improvement in the static group.
At baseline, the degenerative group demonstrated greater postural sway compared with
static and control groups, but neither degenerative or static group exhibited significant
change in postural sway or dynamic weight shifting over one year. The degenerative
cerebellar group walked slower and took shorter strides, while the static group walked
faster and took longer strides over one year. However, changes in gait parameters
were not statistically significant. These authors were unable to detect a statistically
significant change in balance or gait parameters in subjects with a variety of cerebellar
disorders over one year, but they did demonstrate significant change in ICARS scores
(Morton et al., 2010). It is possible that one year may not have been long enough to
detect a significant change in objective balance and gait measures. Another longitudinal
study examined the rate of disease progression in people with FA over one and two
years using the FARS and reported that the FARS could detect changes at two years
but did not detect changes at one year (Friedman, 2010).
The present longitudinal study demonstrated a gradual decline in both gait and
balance in adults with FA over time, but these individuals were not involved in
rehabilitation during the course of the study. Intervention studies have shown the benefit
of physical therapy or adaptive equipment, but also emphasized these interventions
only slow the decline inherent in degenerative diseases. Larger clinical trials with
individuals with cerebellar or sensory ataxia have shown the benefit of physical therapy
interventions and their effect on gait and balance over time (Ilg et al., 2010; 2009; Keller
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et al., 2014; Missaoui et al., 2013; Miyai, 2012). Ilg and colleagues (2009) examined the
effect of a 4 week intensive coordination training program for 16 patients with either
cerebellar degeneration (n=10) or sensory ataxia (n=6). The sensory group included 3
patients with FA, however, results for FA subjects were not analyzed separately.
Primary outcome measures included the SARA, ICARS, BBS and balance and gait
parameters attained using motion analysis. Assessments were conducted 8 weeks
before, immediately before, immediately after, and 8 weeks after training. Results
revealed a significant decrease in ataxia as measured by the SARA, as well as,
improved static and dynamic balance in the cerebellar group immediately after training.
Subjects with cerebellar ataxia exhibited a greater improvement in gait velocity, lateral
body sway and limb coordination than the sensory group. Follow-up assessment
revealed retention of improvements at 8 weeks for the cerebellar group, but not for the
sensory ataxia group, The same authors conducted a follow-up study of the same
subjects one year after the training program and reported that despite a gradual
increase in ataxia due to disease progression in both groups, the cerebellar group
retained improvements in ADLs and motor performance one year after training (Ilg et
al., 2010). The sensory ataxia group exhibited less improvement after the 4 week
training program with no retention at 8 weeks or one year follow-up. This longitudinal
study was similar to the present study in that both used quantitative measures of gait
and balance and clinical rating scales including the BBS to test changes in gait and
balance over time. Ilg and colleagues (Ilg et al., 2010; 2009) were able to demonstrate a
slowing of the decline in gait and balance in subjects with pure cerebellar ataxia using
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intensive rehabilitation; whereas subjects with sensory ataxia including FA did not retain
benefit from the program.

Linear Mixed Effect Model
This study incorporated a linear mixed effect (LME) model for statistical analysis.
The LME model was determined to be a useful statistical method to investigate changes
in gait and balance occurring over two years in adults with FA. This model was selected,
in part, because one subject dropped out of the study after 12 months testing. The LME
model allows more flexibility with fewer assumptions and more statistical power than
alternative methods, such as repeated measures ANOVA (Tang et al., 2014). In
addition, the model allows for the use of unbalanced data and does not exclude
subjects with incomplete data while still describing how individuals and groups change
over time (Finucane et al., 2007). Current findings are consistent with other studies,
which have examined longitudinal changes in postural control and gait in other
neurological populations (Lorenz et al., 2012; Mancini et al., 2012). Mancini and
colleagues (2012) used 3D accelerometers mounted on the posterior trunk of 13
subjects with Parkinson’s disease and 12 healthy control subjects to investigate
changes in 4 measures of postural sway from baseline to 6 month and 12 month followup. To assess longitudinal change in postural sway measures and differences between
groups, these authors employed a LME model followed by a Bonferroni pairwise
correction for multiple comparisons. Postural sway measures did not change in healthy
controls over time and showed low variability between subjects. The patients with
Parkinson’s disease were divided into 2 groups; those who began medications in the
93

first 3 months of the trial and those who did not. The untreated subjects showed an
increase in all 4 measures of postural sway from baseline to 12 month follow-up
suggesting a progressive worsening in balance over time, while those who took
medication showed a slight decrease only in medial lateral sway measures. These
authors concluded that the LME model was a robust statistical method for analyzing
longitudinal change in quantitative balance measures in patients with Parkinson’s
disease (Mancini et al., 2012). Lorenz and colleagues (2012) used the LME model to
investigate progress over time in BBS scores, 6 minute walk test, and 10 meter walk
test of 337 patients with incomplete spinal cord injury who were receiving locomotor
training on a treadmill. They stated that the LME model was able to predict average
performance on an outcome measure over time considering certain covariates while
allowing for individual patient variation in recovery rates. Using the LME model, results
showed a significant improvement on each outcome measure and significant
attenuation of improvement over time. Subjects varied significantly across groups by
ASIA impairment level and time since spinal cord injury and in their rates of change over
time. These authors concluded that locomotor training on a treadmill resulted in
significant improvement in functional outcome measures, including the BBS, and
improvement increased as treatment sessions accumulated (Lorenz et al., 2012).

Relationships among Variables
Disease duration of subjects in the present study ranged from 6 to 16 years. The
findings established a relationship between age of onset, disease duration and gait
variability. Greater gait variability may be exhibited by adults with FA who have longer
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disease duration. These findings concur with those determined in children and
adolescents with FA and extend results to adults (Croarkin et al., 2009). Croarkin and
colleagues (Croarkin et al., 2009) reported a negative correlation between age and gait
velocity and between age and stride length in children and adolescents with FA. The
authors suggested that disease progression in older adolescents with FA might lead
them to walk more slowly and take shorter strides. This also suggests that disease
onset at an earlier age in childhood may significantly affect walking ability by
adolescence. Conversely, young adults, who have relatively later onset of disease in
adolescence (as was the case in present study) may not experience a rapid decline in
their walking until adulthood. Croarkin and colleagues (2009) emphasized the
importance of quantifying gait parameters and investigating the association between
age and age of FA symptom onset and gait parameters. They suggest this information
could improve assessment of a child or adolescent’s disease status at different phases
of maturation. We postulate that studies of FA gait and balance should focus on specific
age groups or should cluster and analyze subject data by age rather than including
subjects across multiple age groups to avoid the confounder of gait changes due to
maturation in children and adolescents. Although the present study did not detect a
significant correlation between subject’s age and gait or balance variables, disease
duration did correlate with FARS total scores at baseline and with step length variability
during fast walking at 24 months. Klockgether and colleagues (1998) studied disease
progression in several different types of ataxia, including FA. They reported disease
progression in FA and Multiple System Atrophy was faster than the other diseases
studied. In addition, they noted patients with early onset recessive ataxias, such as FA,
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reached advanced disease stages at a younger age. Finally, they determined that time
until confinement to a wheelchair was shorter for patients with FA who had earlier
disease onset; specifically, the median time from disease onset to confinement to a
wheelchair was 11 years (Klockgether et al., 1998). LaPean and colleagues (2008)
examined disease progression, including loss of ambulation and ADLs, and the
association of disease progression to GAA repeat length, age of onset, and age of
diagnosis in a study of 61 subjects with FA. They reported age at FA diagnosis was
predictive of wheelchair use and was the most significant variable predicting loss of
ambulation (La Pean et al., 2008). Thus, individuals with earlier disease onset appear to
have a less favorable prognosis. Findings of the present study demonstrated a positive
correlation between disease duration and gait variability in adults with FA. Increased
gait variability in those with longer disease duration may increase the likelihood for loss
of ambulation and dependence on a wheelchair for mobility.
Our findings demonstrated a significant negative correlation between BBS scores
and step and stride length variability at baseline. Lower BBS scores are indicative of
worse static and dynamic balance and impaired dynamic balance has been shown to be
related to greater gait variability (Schniepp et al., 2014). Our findings are in agreement
with results of a study of people with incomplete SCI, who had reduced lower extremity
somatosensation, proprioception, and muscle strength (Day et al., 2012). These authors
reported an inverse relationship between BBS scores and gait variability in subjects with
incomplete SCI. Specifically, they reported BBS scores were significantly inversely
related to step length and anterior-posterior and mediolateral foot placement variability
(Day et al., 2012). These authors proposed that intact dynamic balance for walking is
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dependent on central nervous system integration of sensory information from the distal
lower extremities and the subsequent motor output to execute the walking task (Day et
al., 2012). The BBS scores in adults with FA were related to both postural stability and
limits of stability scores, as well as to gait velocity at 24 month follow-up. Specifically,
lower BBS scores were related to lower limits of stability scores; the latter reflective of
dimished dynamic standing balance. In addition, lower BBS scores were related to
slower gait velocity and decreased cadence, which establishes evidence for the
relationship between impaired balance and gait ataxia in adults with FA. FARS total
scores were associated with the anterior-posterior postural stability index, limits of
stability scores and with step and stride length variability during fast walking at 24
months.
The present study demonstrated several significant relationships between
objective balance and gait parameters. It is the first study to investigate the relationships
between clinical rating scale scores and objective measures of both balance and gait
and how these relationships change over time. The most striking finding was the strong
and consistent relationship between postural stability indices, limits of stability scores,
and step and stride length variability. The postural stability indices are an indicator of
static standing balance, and do not relate as strongly to the balance required to perform
a dynamic task like walking. The limits of stability scores, more indicative of dynamic
balance, displayed a strong relationship to step and stride length variability at both
baseline and 24 months. Others have illustrated a relationship between dynamic
balance and gait variability in people with other neuromuscular disorders (Day et al.,
2012; Grimbergen et al., 2008; Socie et al., 2013). The present study is the first to
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establish a significant relationship between dynamic balance impairment and gait
variability in adults with FA. Milne and colleagues (2014) recently conducted a study of
13 individuals with FA (ages 16-52 yrs.) investigating the relationship between
spatiotemporal gait parameters at varying speeds, as measured by the GAITRite
system, and clinical tests of disease severity (FARS, Timed 25 Foot Walk Test). They
reported significant correlations between gait parameters (at self-selected, slow and fast
walking speeds) and both FA disease duration and FARS total scores. During fast
walking, gait speed and cadence declined with increased FARS scores and disease
duration. There was also a correlation between the Timed 25 Foot Walk Test and mean
gait velocity at all three speeds. The authors concluded spatiotemporal gait parameters,
as measured by the GAITRite system, are a sensitive measure of the decline in gait
observed in people with FA, however, this was not a longitudinal study. They suggested
quantitative gait analysis may provide a more sensitive measure, which is able to detect
more subtle changes in gait, than can be determined using performance measures such
as the Timed 25 Foot Walk Test (Milne et al., 2014). Our longitudinal findings
demonstrated that gait parameters, as measured by the GAITRite system, were
sensitive to detect changes in gait over a two year period of time in adults with FA. The
results differ from the previous study by establishing a significant relationship between
FARS total scores and step and stride length variability during fast walking, but FARS
total scores were not related to gait speed. FARS upright stability scores did not
correlate with balance or gait parameters in the present study. This is different from
results presented by Milne (2014), who found an association between FARS upright
stability scores and intra-individual gait variability. In summary, the present study
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demonstrated significant relationships between clinical rating scale scores and objective
gait and balance parameters in adults with FA; which corroborate findings of other
studies of cerebellar ataxia and other neurological disorders.

Limitations of the Study
The main limitation of this study is the small sample size. It was difficult to recruit
subjects because FA is a relatively rare disease. Additionally, the inclusion criteria did
not allow subjects to be involved in drug trials while participating in this study. Attrition
resulted in loss of one subject after 12 month testing, therefore, data at 24 months are
based on seven subjects with FA. Further investigation with a larger sample size will be
needed to extend the results to a wider FA population.

Implications of Findings
Although this was a pilot study, it is the first longitudinal, natural history study of
adults with FA to characterize gait and balance impairment and demonstrate changes in
gait and balance over time using quantitative measures and clinical rating scales. This
study examined the correlation between clinical rating scale scores, balance and gait
parameters. Knowledge of balance and gait characteristics may assist physical
therapists to predict future decline in functional ambulation in adults with FA.
Significantly decreased gait velocity and increased gait variability, as observed in the
present study, may be predictive of future functional decline in walking, as well as
increased falls risk. For many individuals with FA, it is in young adulthood that balance
and gait become progressively more involved. This leads to a loss of ambulation and
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reliance on a wheelchair or other assistive devices for mobility. At the same time, this is
a period in life when these individuals are pursuing an education, establishing careers,
and supporting themselves or a family. Attainment of these important life goals are
made more challenging by the worsening balance and gait disability. The results of this
study may provide information to support the inclusion of physical therapy management
enabling individuals with FA to ambulate independently for as long as possible.
Physical therapists need to understand FA gait and balance deficits in order to provide
evidence based interventions during optimal time periods. This knowledge would also
allow patients, families, and health professionals to plan in terms of rehabilitation needs
and the need for equipment or environmental modifications.

Future Directions
A longer, longitudinal study (5-10 years) with a larger cohort of subjects with FA
is needed to continue investigation of changes over time in gait and balance in this
population. Future studies should include newer technology and software programs for
quantitative gait and balance testing, but should retain the Berg Balance Scale and the
FARS. Future longitudinal studies could include subjects across age groups, however,
the cohort should be clustered by age allowing for separate analyses by age group. Use
of instrumented measures could monitor possible improvement, or reveal a slowing of
decline in gait and balance as an integral component of new drug trials. Finally,
quantitative gait and balance measures and clinical rating scales could be utilized to
investigate the evidence for neurorehabilitation interventions, which may also have a
role in slowing the decline in balance and gait in people with FA. To date, most research
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investigating rehabilitation interventions for FA have been single case studies or have
not focused on the FA population exclusively (Goulipian et al., 2008; Harris-Love et al.,
2004; Ilg et al., 2010; 2009).

Conclusions
This is the first longitudinal study of adults with FA to show change over time in
both gait and balance variables using both quantitative measures and clinical rating
scales. This study provided a detailed characterization of the gait pattern of adults with
FA and information regarding both static and dynamic balance. The Berg Balance Scale
proved to be a sensitive assessment tool to detect change over time in balance in adults
with FA.
This study determined that the longer time since onset of FA symptoms, the
more compromised the postural control and gait variability. We identified significant
relationships between balance and gait parameters. A striking finding was the strong
and consistent relationship between postural stability indices, limits of stability scores
and step and stride length variability. A significant relationship between BBS and FARS
total scores and gait variability was also shown. Quantitative measures of gait and
balance, the GAITRite Mat and the Biodex Balance System, respectively, were sensitive
measures able to detect change over time in gait and balance in this patient cohort.
Future longitudinal studies of gait and balance in FA should include quantitative
gait and balance measures in addition to clinical rating scales to investigate changes
over time in a larger cohort of subjects. Knowledge of gait and balance impairment in
this population is critical to physical therapists to provide appropriate adaptive and
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assistive devices and to provide interventions during optimal time periods. Further, this
information could assist all health professionals to predict future decline in functional
mobility and assist in decision making as they provide care and treatment to individuals
with FA.
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